Personnel Information

写真a

HARADA Hiroyuki


Job title

Professor

Laboratory Phone number

+81-3-5803-5507

Graduating School 【 display / non-display

  • Hokkaido University, Faculty of Dentistry, 1991, Graduated

Campus Career 【 display / non-display

  • 2010.04
    -
    2015.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Oral Health Sciences, Oral and Maxillofacial Surgery, Associate Professor
  • 2015.04
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Oral Health Sciences, Oral and Maxillofacial Surgery, Professor
  • 2018.04
    -
    2020.05
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Oral Health Sciences, Oral and Maxillofacial Surgery, Professor
  • 2020.06
    -
    2022.06
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Oral Health Sciences, Oral and Maxillofacial Surgery, Professor
  • 2022.07
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Oral Health Sciences, Department of Oral and Maxillofacial Surgical Oncology, Professor

Research Areas 【 display / non-display

  • Surgical dentistry

 

Published Papers & Misc 【 display / non-display

  1. Tanaka K, Harada H, Kayamori K, Omura K. Chronic sclerosing sialadenitis of the submandibular gland as the initial symptom of IgG4-related disease: a case report. Tohoku J Exp Med. 2015.07; 236 (3): 193-198. ( PubMed, DOI )

  2. Haobam Bijaya, Nozawa Takashi, Minowa-Nozawa Atsuko, Tanaka Misako, Oda Seiichiro, Watanabe Takayasu, Aikawa Chihiro, Maruyama Fumito, Nakagawa Ichiro. Rab17-mediated recycling endosomes contribute to autophagosome formation in response to Group A Streptococcus invasion. Cell Microbiol. 2014.12; 16 (12): 1806-1821. ( PubMed, DOI )

  3. Mochizuki Yumi, Omura Ken, Harada Hiroyuki, Marukawa Eriko, Shimamoto Hiroaki, Tomioka Hirofumi. Functional outcomes and patient satisfaction after vascularized osteocutaneous scapula flap reconstruction of the mandible in patients with benign or cancerous tumours. Int J Oral Maxillofac Surg. 2014.11; 43 (11): 1330-1338. ( PubMed, DOI )

  4. Kudoh Masanori, Harada Hiroyuki, Matsumoto Koshi, Sato Yuriko, Omura Ken, Ishii Yoshimasa. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014.10; 118 (4): e105-e110. ( PubMed, DOI )

  5. Takahara Namiaki, Imai Hideki, Nakagawa Satoshi, Sumikura Kanako, Tsushima Fumihiko, Omura Ken. Temporomandibular joint intermittent closed lock: clinic and magnetic resonance imaging findings. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014.10; 118 (4): 418-423. ( PubMed, DOI )

  6. Shirakawa Jumpei, Ezura Yoichi, Moriya Shuichi, Kawasaki Makiri, Yamada Takayuki, Notomi Takuya, Nakamoto Tetsuya, Hayata Tadayoshi, Miyawaki Atsushi, Omura Ken, Noda Masaki. Migration linked to FUCCI-indicated cell cycle is controlled by PTH and mechanical stress. J Cell Physiol. 2014.10; 229 (10): 1353-1358. ( PubMed, DOI )

  7. Mochizuki Yumi, Omura Ken, Harada Hiroyuki, Marukawa Eriko, Shimamoto Hiroaki, Tomioka Hirofumi. Functional outcomes with dental prosthesis following simultaneous mandibulectomy and mandibular bone reconstruction. J Prosthodont Res. 2014.10; 58 (4): 259-266. ( PubMed, DOI )

  8. Omura Ken. Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma. Int J Clin Oncol. 2014.06; 19 (3): 423-430. ( PubMed, DOI )

  9. Matsukawa Sho, Morita Kei-ichi, Negishi Ayako, Harada Hiroyuki, Nakajima Yusuke, Shimamoto Hiroaki, Tomioka Hirofumi, Tanaka Kae, Ono Masaya, Yamada Tesshi, Omura Ken. Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma. Cancer Med. 2014.04; 3 (2): 349-361. ( PubMed, DOI )

  10. Yamamoto Shinsuke, Inoue Jun, Kawano Tatsuyuki, Kozaki Ken-ichi, Omura Ken, Inazawa Johji. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol Cancer Res. 2014.01; 12 (1): 58-68. ( PubMed, DOI )

  11. Rushatamukayanunt Pradit, Morita Kei-ichi, Matsukawa Sho, Harada Hiroyuki, Shimamoto Hiroaki, Tomioka Hirofumi, Omura Ken. Lack of association between high-risk human papillomaviruses and oral squamous cell carcinoma in young Japanese patients. Asian Pac J Cancer Prev. 2014; 15 (10): 4135-4141. ( PubMed )

  12. Kudoh Masanori, Harada Hiroyuki, Sato Yuriko, Omura Ken, Ishii Yoshimasa. A case of Basal cell adenoma of the upper lip. Case Rep Med. 2014; 2014 795356. ( PubMed, DOI )

  13. Kudoh Masanori, Harada Hiroyuki, Omura Ken, Ishii Yoshimasa. Epidermoid cyst arising in the submandibular region. Case Rep Med. 2013; 2013 419289. ( PubMed, DOI )

  14. Takahiro Naito, Rika Noji, Takuma Kugimoto, Takeshi Kuroshima, Hirofumi Tomioka, Shun Fujiwara, Mitsukuni Suenaga, Hiroyuki Harada, Yoshihito Kano. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck. Medicina (Kaunas). 2023.12; 59 (12): 2111. ( PubMed, DOI )

  15. Shiori Tokizaki, Katarzyna A Podyma-Inoue, Takehisa Matsumoto, Kazuki Takahashi, Miho Kobayashi, Haruka Ibi, Shizuka Uchida, Sadahiro Iwabuchi, Hiroyuki Harada, Shinichi Hashimoto, Kohei Miyazono, Mikako Shirouzu, Tetsuro Watabe. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. Cancer Sci. 2023.11; ( PubMed, DOI )

  16. Takuma Kugimoto, Naoto Nishii, Yu Oikawa, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Junichiro Sakamoto, Joe Iwanaga, R Shane Tubbs, Tohru Ikeda, Masahiko Miura, Hiroyuki Harada. Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion pattern. Front Oncol. 2023.10; 13 1168376. ( PubMed, DOI )

  17. Sato J, Kodaira M, Harada H, Iguchi H, Yoshida T, Shibata H, Diagnosis and treatment of bone metastasis: comprehensive guideline (the 2nd Edition) developing group. Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2023.10; 10781552231203720. ( PubMed, DOI )

  18. Akihiro Homma, Mizuo Ando, Nobuhiro Hanai, Hiroyuki Harada, Yoshitaka Honma, Tomonori Kanda, Satoshi Kano, Daisuke Kawakita, Naomi Kiyota, Yoshiyuki Kizawa, Masahiro Nakagawa, Takenori Ogawa, Hirotaka Shinomiya, Takeshi Shinozaki, Motoyuki Suzuki, Tetsuya Tsuji, Koichi Yasuda, Sadamoto Zenda, Takeshi Kodaira, Tadaaki Kirita, Ken-Ichi Nibu. Summary of Japanese clinical practice guidelines for head and neck cancer - 2022 update edited by the Japan society for head and neck cancer. Auris Nasus Larynx. 2023.07; S0385-8146 (23): 00140-2. ( PubMed, DOI )

  19. Akaike Y, Morita K, Sakamoto K, Tsushima F, Kayamori K, Maruta N, Yamazaki K, Anzai E, Tonouchi E, Harada H, Ikeda T, Yoda T.. 口腔扁平苔癬様病変に伴う海綿状態の機械学習を使用した自動検出 Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2023.07; 35 (4): 368-374. ( DOI ichushi )

  20. Pissacha Daroonpan, Ryo Ouchi, Chenyang Zhang, Shigenori Nagai, Naoto Nishii, Yoshihisa Kashima, Fumihiko Tsushima, Hiroyuki Harada, Miwako Hamagaki, Tohru Ikeda, Jun Aida, Ruchadaporn Kaomongkolgit, Miyuki Azuma. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence. Oral Oncol. 2023.06; 143 106458. ( PubMed, DOI )

  21. Ito K, Tokura S, Takazawa I, Yoshida N, Nakanishi T, Akiyama K, Onuma Y, Adachi T, Harada H, Nojima H, Miura M, Yoshimura R, Kabasawa Y. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer. Heliyon. 2023.05; 9 (6): e15869. ( PubMed, DOI )

  22. Hideaki Hirai, Naoto Nishii, Yu Oikawa, Toshimitsu Ohsako, Takuma Kugimoto, Takeshi Kuroshima, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Tohru Ikeda, Hiroyuki Harada. Buccinator muscle invasion is a risk factor for cervical lymph node metastasis in squamous cell carcinoma of the buccal mucosa: A retrospective study. Oncol Lett. 2023.04; 25 (6): 226. ( PubMed, DOI )

  23. Atsushi Uesugi, Fumihiko Tsushima, Youji Miyamoto, Hiroyuki Harada. Pollen Food Allergy Syndrome Caused by Japanese Radish: A Case Report. Indian J Dermatol. 2023.02; 68 (1): 123. ( PubMed, DOI )

  24. Misako Tanaka, Hiroyuki Harada, Hiroshi Kimura. The role of H3K9me3 in oral squamous cell carcinoma. Biochem Biophys Res Commun. 2023.01; 640 56-63. ( PubMed, DOI )

  25. Hirai Hideaki, Kayamori Kou, Noji Rika, Kuroshima Takeshi, Ikeda Tohru, Harada Hiroyuki. 軟口蓋に孤立性の口腔内表在性血管粘液腫が生じた稀な1症例(A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate) Journal of Oral Science. 2023.01; 65 (1): 69-71. ( ichushi )

  26. Kinoshita N, Tomioka H, Oikawa Y, Fukawa Y, Ikeda T, Harada H. A case of sclerosing odontogenic carcinoma of the mandible with a review of the literature. Journal of oral science. 2023; 65 (4): 281-283. ( PubMed, DOI )

  27. Kugimoto T, Yamagata Y, Ohsako T, Hirai H, Nishii N, Kayamori K, Ikeda T, Harada H.. Massive low-grade myxoid liposarcoma of the floor of the mouth: A case report and review of literature. World J Clin Cases. 2022.12; 10 (34): 12742-12749. ( PubMed, DOI )

  28. Ohyama Y, Yamashiro M, Michi Y, Uzawa N, Myo K, Sonoda I, Sumino J, Miura C, Mizutani M, Yamamoto D, Kayamori K, Yoda T. Determination of Significant Prognostic Factors for Maxillary Gingival Squamous Cell Carcinoma in 90 Cases Indian J Otolaryngol Head Neck Surg. 2022.12; 74 (3): 5930-5935. ( PubMed, DOI )

  29. Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model Radiat Res. 2022.12; 198 (6): 632-638. ( PubMed, DOI )

  30. Machitani M, Takei J, Kaneko MK, Ueki S, Ohashi H, Watashi K, Kato Y, Masutomi K. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2 Virol J. 2022.12; 19 (1): 213. ( PubMed, DOI )

  31. Hirai H, Kayamori K, Noji R, Kuroshima T, Ikeda T, Harada H. A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate. J Oral Sci. 2022.11; 65 (1): 69-71. ( PubMed, DOI )

  32. Tsukamoto K, Tanahashi A, Harada H, Takaoka M, Sohara H. Development of a new HotBalloon™ ablation catheter equipped with a balloon surface temperature monitoring sensor for pulmonary vein isolation. J Med Eng Technol. 2022.11; 46 (8): 687-692. ( PubMed, DOI )

  33. Nishii N, Hirotsu Y, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer J Oral Maxillofac Surg Med Pathol. 2022.11; 34 (6): 833-841. ( DOI )

  34. Nojima H, Kaida A, Kuroshima T, Yoshimura RI, Miura M. Retrograde Migration of an Au-198 Grain to the Submandibular Gland Post Brachytherapy Treatment of Floor of Mouth Cancer Cureus. 2022.11; 14 (11): e31904. ( PubMed, DOI )

  35. Nishii Naoto, Hirotsu Yosuke, Takahashi Yukinobu, Takagawa Yuki, Amemiya Kenji, Oyama Toshio, Mochizuki Hitoshi, Furusawa-Nishii Emi, Harada Hiroyuki, Omata Masao. PD-L1陰性の進行口腔癌において好中球・リンパ球比の動的変化を観察することはニボルマブへの治療反応を評価するのに役立つ(Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2022.11; 34 (6): 833-841. ( ichushi )

  36. Takuya Komiyama, Takeshi Kuroshima, Takehito Sugasawa, Shin-Ichiro Fujita, Yuta Ikami, Hideaki Hirai, Fumihiko Tsushima, Yasuyuki Michi, Kou Kayamori, Fumihiro Higashino, Hiroyuki Harada. High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma. Oncol Rep. 2022.10; 48 (4): 183. ( PubMed, DOI )

  37. Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model. Radiat Res. . 2022.10; ( DOI )

  38. Otsuki Shuya, Hori Ryusuke, Shinohara Shogo, Kojima Tsuyoshi, Tamaki Hisanobu, Asato Ryo, Kitamura Morimasa, Ichimaru Kazuyuki, Kitani Yoshiharu, Kumabe Yohei, Honda Keigo, Tsujimura Takashi, Harada Hiroyuki, Ushiro Koji, Omori Koichi. 再発・転移性頭頸部扁平上皮癌に対するニボルマブ投与患者の実臨床での2年間の長期予後および予後因子(Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck) Auris・Nasus・Larynx. 2022.10; 49 (5): 834-844. ( ichushi )

  39. Yanamoto S, Michi Y, Otsuru M, Inomata T, Nakayama H, Nomura T, Hasegawa T, Yamamura Y, Yamada SI, Kusukawa J, Yamakawa N, Hasegawa O, Ueda M, Kitagawa Y, Hiraki A, Hasegawa T, Ohiro Y, Kobayashi W, Asoda S, Kobayashi T, Iino M, Fukuda M, Ishibashi-Kanno N, Kawaguchi K, Aijima R, Noguchi K, Okura M, Tanaka A, Sugiura T, Shintani Y, Yagihara K, Yamashiro M, Ota Y, Miyazaki A, Takeshita A, Kawamata H, Hiroshi I, Uchida K, Umeda M, Kurita H, Kirita T. Protocol for a multicentre, prospective observational study of elective neck dissection for clinically node-negative oral tongue squamous cell carcinoma (END-TC study) BMJ Open. 2022.09; 12 (9): e059615. ( PubMed, DOI )

  40. Tsushima F, Sakurai J, Shimizu R, Kayamori K, Harada H. Oral lichenoid contact lesions related to dental metal allergy may resolve after allergen removal. J Dent Sci. 2022.07; 17 (3): 1300-1306. ( PubMed, DOI )

  41. Rika Noji, Kohki Tohyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Akihisa Tasaki, Kazuchika Ohno, Yosuke Ariizumi, Iichiroh Onishi, Mitsukuni Suenaga, Takehiko Mori, Ryuichi Okamoto, Ryoichi Yoshimura, Masahiko Miura, Takahiro Asakage, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada, Yoshihito Kano. Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers (Basel). 2022.07; 14 (14): 3476. ( PubMed, DOI )

  42. Xie CY, Satake-Ozawa M, Rashed F, Khan M, Ikeda M, Hayashi S, Sawada S, Sasaki Y, Ikeda T, Mori Y, Akiyoshi K, Aoki K. Perforated Hydrogels Consisting of Cholesterol-Bearing Pullulan (CHP) Nanogels: A Newly Designed Scaffold for Bone Regeneration Induced by RANKL-Binding Peptides and BMP-2 Int J Mol Sci. 2022.07; 23 (14): 7768. ( PubMed, DOI )

  43. Okuyama K, Yanamoto S. TMEM16A as a potential treatment target for head and neck cancer J Exp Clin Cancer Res. 2022.06; 41 (1): 196. ( PubMed, DOI )

  44. Hiromitsu Sato, Peng Chen, Maki Ashida, Yusuke Tsutsumi, Hiroyuki Harada, Takao Hanawa. Evaluation of cytocompatibility and osteoconductivity of Zr-14Nb-5Ta-1Mo alloy with MC3T3-E1 cells. Dent Mater J. 2022.05; 41 (3): 421-428. ( PubMed, DOI )

  45. Sato Hiromitsu, Chen Peng, Ashida Maki, Tsutsumi Yusuke, Harada Hiroyuki, Hanawa Takao. MC3T3-E1細胞によるZr-14Nb-5Ta-1Mo合金の細胞適合性と骨伝導性の評価(Evaluation of cytocompatibility and osteoconductivity of Zr-14Nb-5Ta-1Mo alloy with MC3T3-E1 cells) Dental Materials Journal. 2022.05; 41 (3): 421-428. ( ichushi )

  46. Harazono Y, Kayamori K, Sakamoto J, Akaike Y, Kurasawa Y, Tsushima F, Sasaki Y, Harada H, Yoda T. Retrospective analysis of schwannoma in the oral and maxillofacial region: clinicopathological characteristics and specific pathology of ancient change. Br J Oral Maxillofac Surg. 2022.04; S0266-4356 (21): 00262-X. ( PubMed, DOI )

  47. Li G, Suzuki H, Takei J, Asano T, Sano M, Tanaka T, Harada H, Mizuno T, Ohishi T, Kawada M, Kaneko MK, Kato Y. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf). Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): 53-58. ( PubMed, DOI )

  48. Nanamiya R, Suzuki H, Takei J, Li G, Goto N, Harada H, Saito M, Tanaka T, Asano T, Kaneko MK, Kato Y. Development of Monoclonal Antibody 281-mG 2a-f Against Golden Hamster Podoplanin. Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (6): 311-319. ( PubMed, DOI )

  49. Goto N, Suzuki H, Ohishi T, Harakawa A, Li G, Saito M, Takei J, Tanaka T, Asano T, Sano M, Kawada M, Kaneko MK, Kato Y. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-EGFR Monoclonal Antibody Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): 67-73. ( DOI )

  50. Widyagarini A, Nishii N, Kawano Y, Zhang C, Azuma M. VSIG4/CRIg directly regulates early CD8+T cell activation through its counter-receptor in a narrow window Biochem Biophys Res Commun. 2022.04; 614 100-106. ( PubMed, DOI )

  51. Takei J, Suzuki H, Asano T, Tanaka T, Kaneko MK, Kato Y. Development of a Novel Anti-mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-terminal Peptide Immunization Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): ( DOI )

  52. Tran PX, Inoue J, Harada H, Inazawa J. Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma. Mol Ther Oncolytics. 2022.03; 24 897-908. ( PubMed, DOI )

  53. Matsuda Y, Yamashita T, Ye J, Yasukawa M, Yamakawa K, Mukai Y, Machitani M, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Yamada S, Takei J, Kaneko MK, Kojima M, Kaneko S, Masaki T, Hirata M, Haba R, Kontani K, Kanaji N, Miyatake N, Okano K, Kato Y, Masutomi K. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs J Pathol. 2022.03; 257 (2): 172-185. ( PubMed, DOI )

  54. Terauchi Masahiko, Marukawa Eriko, Hyodo Katsuya, Iwasaki Takuya, Wada Akane, Harada Hiroyuki, Yoda Tetsuya. 下歯槽神経を温存しつつ行った歯原性粘液腫の保存的外科治療(Conservative surgical treatment of odontogenic myxoma with preservation of the inferior alveolar nerve) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2022.03; 34 (2): 156-163. ( ichushi )

  55. Kaho Takada, Tomoki Chiba, Takayuki Miyazaki, Lisa Yagasaki, Ryo Nakamichi, Takanori Iwata, Keiji Moriyama, Hiroyuki Harada, Hiroshi Asahara. Single Cell RNA Sequencing Reveals Critical Functions of Mkx in Periodontal Ligament Homeostasis Front Cell Dev Biol. 2022.02; 10 795441. ( PubMed, DOI )

  56. Li G, Suzuki H, Takei J, Saito M, Goto N, Uchida K, Nakagawa T, Harada H, Tanaka T, Asano T, Kaneko MK, Kato Y.. Immunohistochemical Analysis Using Monoclonal Antibody PMab-269 Against Steller Sea Lion Podoplanin. Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): 39-44. ( PubMed, DOI )

  57. Kawabata H, Suzuki H, Takei J, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD10 Monoclonal Antibody (MME/1870) using Enzyme-Linked Immunosorbent Assay Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): ( DOI )

  58. Nanamiya R, Takei J, Ohishi T, Asano T, Tanaka T, Sano M, Nakamura T, Yanaka M, Handa S, Tateyama N, Harigae Y, Saito M, Suzuki H, Kawada M, Kaneko MK, Kato Y. Defucosylated Anti-EGFR Monoclonal Antibody (134-mG2a-f) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): ( DOI )

  59. Rika Noji, Yoshihito Kano, Hideaki Hirai, Iichiroh Onishi, Naoto Nishii, Ryoichi Yoshimura, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral Oncol. 2022.01; 124 105666. ( PubMed, DOI )

  60. Yumi Mochizuki, Maiko Tsuchiya, Jun Oyama, Akane Wada, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroyuki Harada, Tohru Ikeda, Takumi Akashi. Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series. J Med Case Rep. 2022.01; 16 (1): 33. ( PubMed, DOI )

  61. Shimizu R, Tsushima F, Komiya R, Yamagata Y, Harada H. Fixed Drug Eruption Associated with Nonsteroidal Anti-Inflammatory Drugs for Menstrual Pain: A Case Report. Case Rep Dermatol. 2022.01; 14 (1): 6-11. ( PubMed, DOI )

  62. Yasuyuki Michi, Hiroyuki Harada, Yu Oikawa, Kohei Okuyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Yumi Mochizuki, Hiroaki Shimamoto, Hirofumi Tomioka, Hirokazu Kachi, Jun-Ichiro Sakamoto, Kou Kayamori, Tetsuya Yoda. Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study. BMC Oral Health. 2022.01; 22 (1): 20. ( PubMed, DOI )

  63. Tsushima F, Sakurai J, Shimizu R, Harada H. A case report of oral lichenoid lesions related to cross-reactivity between nickel and palladium. Contact Derm. 2021.12; 85 (6): 700-701. ( PubMed, DOI )

  64. Li G, Ohishi T, Kaneko MK, Takei J, Mizuno T, Kawada M, Saito M, Suzuki H, Kato Y. Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors. Cells. 2021.12; 10 (12): 3599. ( PubMed, DOI )

  65. Terasawa K, Kato Y, Ikami Y, Sakamoto K, Ohtake K, Kusano S, Tomabechi Y, Kukimoto-Niino M, Shirouzu M, Guan JL, Kobayashi T, Iwata T, Watabe T, Yokoyama S, Hara-Yokoyama M. Direct homophilic interaction of LAMP2A with the two-domain architecture revealed by site-directed photo-crosslinks and steric hindrances in mammalian cells. Autophagy. 2021.12; 17 (12): 4286-4303. ( PubMed, DOI )

  66. Shimono H, Hirai H, Oikawa Y, Mochizuki Y, Kuroshima T, Tomioka H, Kayamori K, Ikeda T, Harada H. Metastatic tumors in the oral region: a retrospective chart review of clinical characteristics and prognosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.12; 132 (6): 648-652. ( PubMed, DOI )

  67. Takei J, Suzuki H, Asano T, Li G, Saito M, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 250-254. ( PubMed, DOI )

  68. Takei J, Asano T, Li G, Saito M, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-Human CCR9 Monoclonal Antibody (C9Mab-1) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 239-242. ( PubMed, DOI )

  69. Asano T, Takei J, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-HER2 Monoclonal Antibody (H2Mab-181) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 255-260. ( PubMed, DOI )

  70. Asano T, Takei J, Furusawa Y, Saito M, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) using the HisMAP Method. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 243-249. ( PubMed, DOI )

  71. Yoshimura R, Toda K, Watanabe H, Kaida A, Harada H, Asakage T, Miura M. Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer. Anticancer Res. 2021.12; 41 (12): 6259-6266. ( PubMed, DOI )

  72. Yuta Ikami, Kazue Terasawa, Kensaku Sakamoto, Kazumasa Ohtake, Hiroyuki Harada, Tetsuro Watabe, Shigeyuki Yokoyama, Miki Hara-Yokoyama. The two-domain architecture of LAMP2A regulates its interaction with Hsc70. Exp Cell Res. 2021.12; 411 (1): 112986. ( PubMed, DOI )

  73. Okuyama K, Michi Y, Kashima Y, Tomioka H, Hirai H, Yokokawa M, Yamagata Y, Kuroshima T, Sato Y, Tsuchiya M, Kayamori K, Ikeda T, Harada H. Epithelial-Myoepithelial Carcinoma of the Minor Salivary Glands: Case Series with Comprehensive Review. Diagnostics. 2021.11; 11 (11): 2124. ( PubMed, DOI )

  74. ティーラウォン・チャンヤーヌット, 坂本 啓, 布川裕規, 土谷麻衣子, 栢森 高, 明石 巧, 濱垣美和子, 富岡博文, 黒嶋雄志, 森田圭一, 原田浩之, 池田 通. 舌癌症例にみられるヒトパピローマウイルス(HPV)感染と無関係なp16免疫染色陽性反応. 口腔病学会雑誌. 2021.11; 88 (2-3): 115-126. ( ichushi )

  75. Hayashi S, Sasaki Y, Kubo H, Sawada S, Kinoshita N, Marukawa E, Harada H, Akiyoshi K. Construction of Hybrid Cell Spheroids Using Cell Sized Cross-Linked Nanogel Microspheres as an Artificial Extracellular Matrix. ACS Appl Bio Mater. 2021.11; 4 (11): 7848-7855. ( PubMed, DOI )

  76. ティーラウォン・チャンヤーヌット , 坂本 啓, 布川 裕規, 土谷 麻衣子, 栢森 高, 明石 巧, 濱垣 美和子, 富岡 博文, 黒嶋 雄志, 森田 圭一, 原田 浩之, 池田 通. 舌癌症例にみられるヒトパピローマウイルス(HPV)感染と無関係なp16免疫染色陽性反応(Immunohistochemical Positivity for p16 Unrelated to Human Papillomavirus(HPV) Infection in Lingual Squamous Cell Carcinomas) 口腔病学会雑誌. 2021.11; 88 (2-3): 115-126. ( ichushi )

  77. Okuyama K, Yanamoto S, Michi Y, Shibata E, Tsuchiya M, Yokokawa M, Naruse T, Tomioka H, Kuroshima T, Shimamoto H, Ikeda T, Umeda M, Yoda T, Harada H. Multicenter retrospective analysis of clinicopathological features and prognosis of oral tongue squamous cell carcinoma in adolescent and young adult patients. Medicine. 2021.10; 100 (41): e27560. ( PubMed, DOI )

  78. Harada H, Tomioka H, Hirai H, Kuroshima T, Oikawa Y, Nojima H, Sakamoto J, Kurabayashi T, Kayamori K, Ikeda T. MRI before biopsy correlates with depth of invasion corrected for shrinkage rate of the histopathological specimen in tongue carcinoma. Sci Rep. 2021.10; 11 (1): 20992. ( PubMed, DOI )

  79. Kuroshima T, Onozato Y, Oikawa Y, Ohsako T, Kugimoto T, Hirai H, Tomioka H, Michi Y, Miura M, Yoshimura R, Harada H. Prognostic impact of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue: a retrospective study. Sci Rep. 2021.10; 11 (1): 20535. ( PubMed, DOI )

  80. Takei J, Asano T, Suzuki H, Kaneko MK, Kato Y. Epitope mapping of the anti-CD44 monoclonal antibody (C44Mab-46) using alanine-scanning mutagenesis and surface plasmon resonance. Monoclon Antib Immunodiagn Immunother. 2021.10; 40 (5): 219-226. ( PubMed, DOI )

  81. Shibata E, Morita KI, Kayamori K, Tange S, Shibata H, Harazono Y, Michi Y, Ikeda T, Harada H, Imoto I, Yoda T. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.10; 132 (4): 426-433. ( PubMed, DOI )

  82. Terauchi M, Marukawa E, Hyodo K, Iwasaki T, Wada A, Harada H, Yoda T. Conservative surgical treatment of odontogenic myxoma with preservation of the inferior alveolar nerve. J Oral Maxillofac Surg Med Pathol. 2021.10; ( DOI )

  83. Fujimura N, Hosokawa K, Obara H, Igari K, Akamatsu D, Matsumoto H, Asami A, Shibutani S, Akiyoshi T, Nunokawa M, Harada H, Inoue K, Koya A, Furuyama T, Sagara D, Shintani T, Yamaoka T, Akiyama Y, Inoue Y, Hoshina K. Incidence, diagnosis and treatment of popliteal artery entrapment syndrome in current vascular practice in Japan. Cardiovascular intervention and therapeutics. 2021.10; 36 (4): 506-513. ( PubMed, DOI )

  84. Harada H, Shimamoto H, Oikawa Y, Kuroshima T, Tomioka H, Hirai H, Tsushima F, Michi Y. Mandibular Reconstruction with Scapular Systems: A Single-Center Case Series Involving 208 Flaps. Plast Reconstr Surg. 2021.09; 148 (3): 625-634. ( PubMed, DOI )

  85. Mochizuki Y, Marukawa E, Harada H, Kinoshita N, Nakatani R, Oikawa Y, Hirai H, Tomioka H, Yoda T, Nakamura S, Kurabayashi T. Postoperative morphological changes over time of vascularized scapular bone used for mandibular reconstruction: A retrospective cohort study. J Plast Reconstr Aesthet Surg. 2021.09; 74 (9): 1984-1990. ( PubMed, DOI )

  86. Kaida A, Yamamoto S, Parrales A, Young ED, Ranjan A, Alalem MA, Morita KI, Oikawa Y, Harada H, Ikeda T, Thomas SM, Diaz FJ, Iwakuma T. DNAJA1 promotes cancer metastasis through interaction with mutant p53. Oncogene. 2021.08; 40 (31): 5013-5025. ( PubMed, DOI )

  87. Tanaka T, Asano T, Sano M, Takei J, Hosono H, Nanamiya R, Tateyama N, Kaneko MK, Kato Y. Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 using Alanine-scanning Mutagenesis and ELISA. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 196-200. ( PubMed, DOI )

  88. Asano T, Ohishi T, Takei J, Nakamura T, Nanamiya R, Hosono H, Tanaka T, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Oncol Rep. 2021.08; 46 (2): 173. ( PubMed, DOI )

  89. Asano T, Kaneko MK, Takei J, Tateyama N, Kato Y. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C44Mab-46) Using the REMAP Method. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 156-161. ( PubMed, DOI )

  90. Takei J, Asano T, Tanaka T, Sano M, Hosono H, Nanamiya R, Tateyama N, Saito M, Suzuki H, Harada H, Kaneko MK, Kato Y. Development of a Novel Anti-HER2 Monoclonal Antibody H2Mab-181 for Gastric Cancer. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 168-176. ( PubMed, DOI )

  91. Aragaki T, Tomomatsu N, Michi Y, Hosaka H, Fukai Y, Iijima M, Yoda T. Ramucirumab-related Oral Pyogenic Granuloma: A Report of Two Cases. Intern Med. 2021.08; 60 (16): 2601-2605. ( PubMed, DOI )

  92. Tateyama N, Asano T, Ohishi T, Takei J, Hosono H, Nanamiya R, Tanaka T, Sano M, Saito M, Kawada M, Kaneko MK, Kato Y. An Anti‐HER2 Monoclonal Antibody H2Mab‐41 Exerts Antitumor Activities in Mouse Xenograft Model using Dog HER2‐overexpressed Cells. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 184-190. ( PubMed, DOI )

  93. Tateyama N, Nanamiya R, Ohishi T, Takei J, Nakamura T, Yanaka M, Hosono H, Saito M, Asano T, Tanaka T, Sano M, Kawada M, Kaneko MK, Kato Y. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG 2a-f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 177-183. ( PubMed, DOI )

  94. Okuyama K, Hayashida S, Rokutanda S, Kawakita A, Soutome S, Sawada S, Yanamoto S, Kojima Y, Umeda M. Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study. J Dent Sci. 2021.07; 16 (3): 885-890. ( PubMed, DOI )

  95. Tanaka T, Ohishi T, Asano T, Takei J, Nanamiya R, Hosono H, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models. Oncol Rep. 2021.07; 46 (1): 132. ( PubMed, DOI )

  96. Fukuda S, Akiyama M, Niki Y, Kawatsura R, Harada H, Nakahama K. Inhibitory effects of miRNAs in astrocytes on C6 glioma progression via connexin 43. Mol Cell Biochem. 2021.07; 476 (7): 2623-2632. ( PubMed, DOI )

  97. Shiba T, Watanabe T, Komatsu K, Koyanagi T, Nemoto T, Ohsugi Y, Michi Y, Katagiri S, Takeuchi Y, Ishihara K, Iwata T. Non-surgical treatment for periodontitis and peri-implantitis: longitudinal clinical and bacteriological findings-A case report with a 7-year follow-up evaluation. SAGE Open Med Case Rep. 2021.07; 9 2050313X211029154. ( PubMed, DOI )

  98. Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, Hirai H, Kayamori K, Harada H. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health. 2021.06; 21 (1): 298. ( PubMed, DOI )

  99. Oikawa Y, Tanaka K, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Shimamoto H, Michi Y, Sakamoto K, Ikeda T, Harada H. Comparison of Clinicopathological Characteristics Between the Anterior and Posterior Type of Squamous Cell Carcinoma of the Floor of the Mouth: The Anterior Type Is a Risk Factor for Multiple Primary Cancer. Front Oncol. 2021.06; 11 682428. ( PubMed, DOI )

  100. Asano A, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Kato Y. Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 107-112. ( PubMed, DOI )

  101. Nanamiya R, Takei J, Asano T, Sano M, Tanaka T, Hosono H, Harada H, Sakai Y, Mizuno T, Suzuki H, Kaneko MK, Kato Y. Ferret Podoplanin is Detected by PMab-241 in Immunohistochemistry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 134-140. ( PubMed, DOI )

  102. Nanamiya R, Takei J, Asano T, Tanaka T, Sano M, Nakamura T, Yanaka M, Hosono H, Kaneko MK, Kato Y. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 101-106. ( PubMed, DOI )

  103. Hosono H, Asano T, Takei J, Sano M, Tanaka T, Kaneko MK, Kato Y. Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow cytometry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 141-145. ( PubMed, DOI )

  104. Tanaka T, Asano T, Sano M, Takei J, Hosono H, Nanamiya R, Nakamura T, Yanaka M, Harada H, Fukui M, Suzuki H, Uchida K, Nakagawa T, Kato Y, Kaneko MK. Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 124-133. ( PubMed, DOI )

  105. Sawa Y, Ibaragi S, Okui T, Yamashita J, Ikebe T, Harada H. Expression of SARS-CoV-2 entry factors in human oral tissue. J Anat. 2021.06; 238 (6): 1341-1354. ( PubMed, DOI )

  106. Yu Oikawa, Takuma Kugimoto, Yoshihisa Kashima, Kohei Okuyama, Toshimitsu Ohsako, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroaki Shimamoto, Yasuyuki Michi, Hiroyuki Harada. Surgical treatment for oral tongue squamous cell carcinoma: A retrospective study of 432 patients. Glob Health Med. 2021.06; 3 (3): 157-162. ( PubMed, DOI )

  107. Oikawa Yu, Kugimoto Takuma, Kashima Yoshihisa, Okuyama Kohei, Ohsako Toshimitsu, Kuroshima Takeshi, Hirai Hideaki, Tomioka Hirofumi, Shimamoto Hiroaki, Michi Yasuyuki, Harada Hiroyuki. 口腔舌扁平上皮癌に対する外科療法 患者432名を対象とした後方視的研究(Surgical treatment for oral tongue squamous cell carcinoma: A retrospective study of 432 patients) Global Health & Medicine. 2021.06; 3 (3): 157-162. ( ichushi )

  108. Yokokawa M, Hirai H, Tran C. M, Fukuda S, Sakamoto K, Ikeda T, Harada H. Adenoid cystic carcinoma metastas E12:T13 ized from the maxilla to the mandible:A case report. J Oral Mxillofac Surg Med Pathol. 2021.05; 33 (3): 371-375. ( DOI )

  109. Yokokawa Misaki, Hirai Hideaki, Tran Cuong Minh, Fukuda Shuhei, Sakamoto Kei, Ikeda Tohru, Harada Hiroyuki. 上顎から下顎へと転移した腺様嚢胞癌 症例報告(Adenoid cystic carcinoma metastasized from the maxilla to the mandible: A case report) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2021.05; 33 (3): 371-375. ( ichushi )

  110. Yamada I, Yohino N, Yokokawa M, Oikawa Y, Harada H, Hikishima K, Kurabayashi T, Saida Y, Tateishi U, Ohata Y. Diffusion tensor imaging of oral carcinoma: Clinical evaluation and comparison with histopathological findings. Magn Reson Imaging. 2021.04; 77 99-108. ( PubMed, DOI )

  111. Tran CM, Kuroshima T, Oikawa Y, Michi Y, Kayamori K, Harada H. Clinicopathological and immunohistochemical characteristics of pigmented oral squamous cell carcinoma. Oncol Lett. 2021.04; 21 (4): 339. ( PubMed, DOI )

  112. Tanaka T, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Sano M, Asano T, Kaneko MK, Kato Y. Development of Anti-Mouse CC chemokine receptor 8 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.04; 40 (2): 65-70. ( PubMed, DOI )

  113. Takei J, Asano T, Nanamiya R, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Harada H, Kato Y. Development of Anti-Human T-Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.04; 40 (2): 71-75. ( PubMed, DOI )

  114. Suga T, Tu TTH, Takenoshita M, Mikuzuki L, Umezaki Y, Shimamoto H, Michi Y, Hong C, Abiko Y, Ikeda T, Uzawa N, Harada H, Toyofuku A. Case Report: Hidden Oral Squamous Cell Carcinoma in Oral Somatic Symptom Disorder. Front Psychiatry. 2021.04; 12 651871. ( PubMed, DOI )

  115. Ota Y, Noguchi T, Ariji E, Fushimi C, Fuwa N, Harada H, Hayashi T, Hayashi R, Honma Y, Miura M, Mori T, Nagatsuka H, Okura M, Ueda M, Uzawa N, Yagihara K, Yagishita H, Yamashiro M, Yanamoto S, Kirita T. General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis. Int J Clin Oncol. 2021.04; 26 (4): 623-635. ( PubMed, DOI )

  116. Ota Yoshihide, Noguchi Tadahide, Ariji Eiichiro, Fushimi Chihiro, Fuwa Nobukazu, Harada Hiroyuki, Hayashi Takafumi, Hayashi Ryuichi, Honma Yoshitaka, Miura Masahiko, Mori Taisuke, Nagatsuka Hitoshi, Okura Masaya, Ueda Michihiro, Uzawa Narikazu, Yagihara Kazuhiro, Yagishita Hisao, Yamashiro Masashi, Yanamoto Souichi, Kirita Tadaaki, Scientific Committee on General Rules for Clinical,Pathological Studies of Oral Cancer,Japanese Society of Oral Oncology. 口腔癌取扱い規約(第2版) 概要(General rules for clinical and pathological studies on oral cancer(2nd edition): a synopsis) International Journal of Clinical Oncology. 2021.04; 26 (4): 623-635. ( ichushi )

  117. Tomioka H, Yamagata Y, Oikawa Y, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Shimamoto H, Harada H. Risk factors for distant metastasis in locoregionally controlled oral squamous cell carcinoma: a retrospective study. Sci Rep. 2021.03; 11 (1): 5213. ( PubMed, DOI )

  118. Sayama Y, Kaneko MK, Takei J, Hosono H, Sano M, Asano T, Kato Y. Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis. Biochem Biophys Rep. 2021.03; 25 100902. ( PubMed, DOI )

  119. Okuyama K, Naruse T, Yanamoto S, Hayashida S, Rokutanda S, Kawakita A, Furukawa K, Umeda M. Prodromal symptoms of streptococcal toxic shock syndrome caused by Group A Streptococcus in the head and neck region: a case report. J Oral Maxillofac Surg Med Pathol. 2021.03; 33 (2): 211-214. ( DOI )

  120. Okuyama K, Suzuki K, Naruse T, Tsuchihashi H, Yanamoto S, Kaida A, Miura M, Umeda M, Yamashita S. Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma. Sci Rep. 2021.03; 11 5259. ( PubMed, DOI )

  121. Fukawa Y, Sakamoto K, Kugimoto T, Michi Y, Harada H, Yamamoto M, Kitagawa M, Ikeda T, Yamamoto K. Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate. Pathol Int. 2021.03; 71 (3): 213-215. ( PubMed, DOI )

  122. Fukawa Yuki, Sakamoto Kei, Kugimoto Takuma, Michi Yasuyuki, Harada Hiroyuki, Yamamoto Masahide, Kitagawa Masanobu, Ikeda Tohru, Yamamoto Kouhei. 硬口蓋に発症した結節性リンパ球優位型Hodgkinリンパ腫(Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate) Pathology International. 2021.03; 71 (3): 213-215. ( ichushi )

  123. Nishii N, Hirotsu Y, Koida N, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers. Anticancer Res. 2021.02; 41 (2): 1035-1040. ( PubMed, DOI )

  124. Baba S, Akashi T, Kayamori K, Ohuchi T, Ogawa I, Kubota N, Nakano K, Nagatsuka H, Hasegawa H, Matsuzaka K, Tomii S, Uchida K, Katsuta N, Sekiya T, Ando N, Miura K, Ishibashi H, Ariizumi Y, Asakage T, Michi Y, Harada H, Sakamoto K, Eishi Y, Okubo K, Ikeda T. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma. Pathol Int. 2021.02; 71 (2): 113-123. ( PubMed, DOI )

  125. Baba Shunichi, Akashi Takumi, Kayamori Kou, Ohuchi Tomoyuki, Ogawa Ikuko, Kubota Nobuhisa, Nakano Keisuke, Nagatsuka Hitoshi, Hasegawa Hiromasa, Matsuzaka Kenichi, Tomii Shohei, Uchida Keisuke, Katsuta Noriko, Sekiya Takahiro, Ando Noboru, Miura Keiko, Ishibashi Hironori, Ariizumi Yousuke, Asakage Takahiro, Michi Yasuyuki, Harada Hiroyuki, Sakamoto Kei, Eishi Yoshinobu, Okubo Kenichi, Ikeda Tohru. ホメオボックス転写因子engrailed homeobox 1は腺様嚢胞癌および多形腺癌の診断マーカーの可能性がある(Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma) Pathology International. 2021.02; 71 (2): 113-123. ( ichushi )

  126. Terauchi M, Michi Y, Hirai H, Sugiyama K, Wada A, Harada H, Yoda T. Prognostic factors in mucoepidermoid carcinoma of the minor salivary glands: A single-center retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.01; 131 (2): 209-216. ( PubMed, DOI )

  127. Sakakitani S, Podyma-Inoue KA, Takayama R, Takahashi K, Ishigami-Yuasa M, Kagechika H, Harada H, Watabe T. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. Cancer Sci. 2021.01; 112 (1): 155-167. ( PubMed, DOI )

  128. Sakakitani Shintaro, Podyma-Inoue Katarzyna A., Takayama Rina, Takahashi Kazuki, Ishigami-Yuasa Mari, Kagechika Hiroyuki, Harada Hiroyuki, Watabe Tetsuro. β2-アドレナリン受容体シグナルの活性化は口腔扁平上皮癌細胞の間葉系表現型を抑制する(Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells) Cancer Science. 2021.01; 112 (1): 155-167. ( ichushi )

  129. Nishii N, Shimamoto H, Ohsako T, Yokokawa M, Sato Y, Ohata Y, Kayamori K, Ikeda T, Harada H. Renal cell carcinoma metastasis to the maxillary bone successfully treated with surgery after vascular embolization: a case report J Med Case Rep. 2020.12; 14 (1): 193. ( PubMed, DOI )

  130. Hosono H, Ohishi T, Takei J, Asano T, Sayama Y, Kawada M, Kaneko MK, Kato Y. The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma Oncol Lett. 2020.12; 20 (6): 383. ( PubMed, DOI )

  131. Kaneko MK, Ohishi T, Takei J, Sano M, Nakamura T, Hosono H, Yanaka M, Asano T, Sayama Y, Harada H, Kawada M, Kato Y. The Anti-EpCAM monoclonal antibody (EpMab-16) exerts anti-tumor activity against oral squamous cell carcinomas Oncol Rep. 2020.12; 44 (6): 2517-2526. ( PubMed, DOI )

  132. Shimono H, Kaida A, Homma H, Nojima H, Onozato Y, Harada H, Miura M. Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency Sci Rep. 2020.11; 10 (1): 20873 (Open access). ( PubMed, DOI )

  133. Uesugi A, Tsushima F, Kodama M, Kuroshima T, Sakurai J, Harada H. Oral granuloma in a pediatric patient with chronic graft-versus-host disease: A case report World J Clin Cases. 2020.11; 8 (22): 5663-5669. ( PubMed, DOI )

  134. Nishimura T, Nakamura Y, Kinoshita N, Yamamoto K, Sasaki Y, Akiyoshi K. Biocatalytic Hybrid Films Self-Assembled from Carbohydrate Block Copolymers and Polysaccharides for Enzyme Prodrug Therapy ACS Appl Bio Mater. 2020.11; 3 (12): 8865-8871. ( DOI )

  135. Takei J, Kaneko MK, Ohishi T, Hosono H, Nakamura T, Yanaka M, Sano M, Asano T, Sayama Y, Kawada M, Harada H, Kato Y. A defucosylated anti-CD44 monoclonal antibody 5-mG2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Oncol Rep. 2020.11; 44 (5): 1949-1960. ( PubMed, DOI )

  136. Hosono H, Takei J, Ohishi T, Sano M, Asano T, Sayama Y, Nakamura T, Yanaka M, Kawada M, Harada H, Kaneko MK, Kato Y. Anti-EGFR monoclonal antibody 134-mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Int J Mol Med. 2020.10; 46 (4): 1443-1452. ( PubMed, DOI )

  137. Kayamori K, Tsuchiya M, Michi Y, Kuribayashi A, Mikami T, Sakamoto K, Yoda T, Ikeda T. Primordial odontogenic tumor occurred in the maxilla with unique calcifications and its crucial points for differential diagnosis Pathol Int. 2020.10; 71 (1): 80-87. ( PubMed, DOI )

  138. Kaneko MK, Ohishi T, Nakamura T, Inoue H, Takei J, Sano M, Asano T, Sayama Y, Hosono H, Suzuki H, Kawada M, Kato Y. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies Monoclon Antib Immunodiagn Immunother. 2020.10; 39 (5): 167-174. ( PubMed, DOI )

  139. Tsuchihashi H, Naruse T, Yanamoto S, Okuyama K, Furukawa K, Omori K, Umeda M. Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab-resistant oral squamous cell carcinoma. Oncol Rep. 2020.09; 44 (3): 863-872. ( PubMed, DOI )

  140. Hirai H, Ohsako T, Kugimoto T, Tomioka H, Michi Y, Kayamori K, Yoda T, Miura M, Yoshimura R, Harada H. Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma Oral Oncol. 2020.08; 107 104708. ( PubMed, DOI )

  141. Shibata E, Morita KI, Kayamori K, Maruiwa M, Michi Y, Sato Y, Takeuchi K, Ikeda T, Harada H, Yoda T. Secretory carcinoma around Stensen's duct misdiagnosed as salivary duct cyst Int J Clin Exp Pathol. 2020.08; 13 (8): 2211-2217. ( PubMed )

  142. Takei J, Ohishi T, Kaneko MK, Harada H, Kawada M, Kato Y. A defucosylated anti-PD-L1 monoclonal antibody 13-mG 2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Biochem Biophys Rep. 2020.08; 30 (24): 100801. ( PubMed, DOI )

  143. Kaneko MK, Sano M, Takei J, Asano T, Sayama Y, Hosono H, Kobayashi A, Konnai S, Kato Y. Development and Characterization of Anti-Sheep Podoplanin Monoclonal Antibodies PMab-253 and PMab-260 Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 144-145. ( PubMed, DOI )

  144. Kato Y, Ohishi T, Takei J, Nakamura T, Kawada M, Kaneko MK. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H2Mab-19) Exerts Antitumor Activity in Glioblastoma Xenograft Models Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 135-139. ( PubMed, DOI )

  145. Kato Y, Ohishi T, Takei J, Nakamura T, Sano M, Asano T, Sayama Y, Hosono H, Kawada M, Kaneko MK. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H 2 Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 123-128. ( PubMed, DOI )

  146. Asano T, Sano M, Takei J, Sayama Y, Kaneko MK, Kato Y. Epitope mapping of the anti-diacylglycerol kinase monoclonal antibody DhMab-4 for immunohistochemical analysis Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 117-122. ( PubMed, DOI )

  147. Kinoshita N, Sasaki Y, Marukawa E, Hirose R, Sawada SI, Harada H, Akiyoshi K. Crosslinked nanogel-based porous hydrogel as a functional scaffold for tongue muscle regeneration J Biomater Sci Polym Ed. 2020.07; 31 (10): 1254-1271. ( PubMed, DOI )

  148. Yamada SI, Hasegawa T, Okuyama K, Yamakawa N, Okura M, Hashidume M, Yanamoto S, Akashi M, Kirita T, Umeda M, Kurita H. Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma Clin Oral Investig. 2020.06; 24 (6): 1953-1961. ( PubMed, DOI )

  149. Takagawa Y , Gen Y, Muramatsu T, Tanimoto K, Inoue J, Harada H, Inazawa J . miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway Mol ther. 2020.06; 28 (6): 1494-1505. ( PubMed, DOI )

  150. Sayama Y, Sano M, Asano T, Furusawa Y, Takei J, Nakamura T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Yanagawa M, Kaneko MK, Kato Y. Epitope mapping of PMab-241, a lymphatic endothelial cell-specific anti-bear podoplanin monoclonal antibody Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 77-81. ( PubMed, DOI )

  151. Kato Y, Ohishi T, Sano M, Asano T, Sayama Y, Takei J, Kawada M, Kaneko MK. H2Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 61-65. ( PubMed, DOI )

  152. Kato Y, Takei J, Sano M, Asano T, Sayama Y, Uchida K, Nakagawa T, Kaneko MK. Detection of lion podoplanin using the anti-tiger podoplanin monoclonal antibody PMab-231 Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 91-94. ( PubMed, DOI )

  153. Kato Y, Furusawa Y, Sano M, Takei J, Nakamura T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Asano T, Sayama Y, Kaneko MK. Development of an Anti-Sheep Podoplanin Monoclonal Antibody PMab-256 for Immunohistochemical Analysis of Lymphatic Endothelial Cells Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 82-90. ( PubMed, DOI )

  154. Uesugi A, Mochida K, Harada H, Imai H. Ossifying fibroma arising from the zygomatic arch: A case report. Journal of stomatology, oral and maxillofacial surgery. 2020.06; 121 (3): 288-291. ( PubMed, DOI )

  155. Kaneko A, Marukawa E, Harada H. Hydroxyapatite Nanoparticles as Injectable Bone Substitute Material in a Vertical Bone Augmentation Model In Vivo. 2020.05; 34 (3): 1053-1061.

  156. Kashima Y, Nishii N, Tachinami H, Furusawa E, Nagai S, Harada H, Azuma M. Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8+ T cells and regulatory T cell-dominance, compared to skin SCC. Biochem Biophys Res Commun. 2020.05; 526 (1): 218-224. ( PubMed, DOI )

  157. Shimamoto H, Hirota Y, Kashima Y, Kinoshita N, Yokokawa M, Ikeda T, Harada H. Granulocyte colony-stimulating factor-producing squamous cell carcinoma of the tongue exhibiting characteristic fluorine-18 deoxyglucose accumulation on positron emission tomography–computed tomography: A case report World J Clin Case. 2020.05; 8 (9): 1666-1673. ( PubMed, DOI )

  158. Naruse T, Yanamoto S, Okuyama K, Ohmori K, Tsuchihashi H, Furukawa K, Yamada SI, Umeda M. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence Pathol Oncol Res. 2020.04; 26 (2): 735-742. ( DOI )

  159. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity Oncol Lett. 2020.04; 19 (4): 2809-2816. ( PubMed, DOI )

  160. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. H2Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts Exp Ther Med. 2020.04; 20 (2): 846-853. ( PubMed, DOI )

  161. Kato Y, Ito Y, Ohishi T, Kawada M, Nakamura T, Sayama Y, Sano M, Asano T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Takei J, Kaneko MK. Antibody–drug conjugates using mouse–canine chimeric anti-dog podoplanin antibody exerts antitumor activity in a mouse xenograft model Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 37-44. ( PubMed, DOI )

  162. Yamada S, Kaneko MK, Sayama Y, Asano T, Sano M, Yanaka M, Nakamura T, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Furusawa Y, Takei J, Kato Y. Development of novel mouse monoclonal antibodies against human CD19 Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 45-50. ( PubMed, DOI )

  163. Ohsako T, Shimamoto H, Tomioka H, Hirai H, Kuroshima T, Mochizuki Y, Kugimoto T, Tsushima F, Nakamura S, Kurabayashi T, Harada H. Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020.03; 129 (3): 272-276. ( PubMed, DOI )

  164. Yokokawa M, Morita KI, Oikawa Y, Kayamori K, Sakamoto K, Ikeda T, Harada H. Co‐expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma J Oral Pathol Med. 2020.03; 49 (3): 235-242. ( PubMed, DOI )

  165. Yahara H, Horita S, Yanamoto S, Kitagawa Y, Asaka T, Yoda T, Morita K, Michi Y, Takechi M, Shimasue H, Maruoka Y, Kondo E, Kusukawa J, Tsujiguchi H, Sato T, Kannon T, Nakamura H, Tajima A, Hosomichi K, Yahara K. A Targeted Genetic Association Study of the Rare Type of Osteomyelitis J Dent Res. 2020.03; 99 (3): 271-276. ( PubMed, DOI )

  166. Yamamoto D, Kayamori K, Sakamoto K, Tsuchiya M, Ikeda T, Harada H, Yoda T, Watabe T, Hara-Yokoyama M. Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis Cancer Sci. 2020.02; 111 (2): 700-712. ( PubMed, DOI )

  167. Yukimori A, Tsuchiya M, Wada A, Michi Y, Kayamori K, Sakamoto K, Ikeda T. Genetic and histopathological analysis of a case of primary intraosseous carcinoma, NOS with features of both ameloblastic carcinoma and squamous cell carcinoma World J Surg Oncol. 2020.02; 18 (1): 45. ( PubMed, DOI )

  168. Nguyen CTK, Sawangarun W, Mandasari K, Morita KI, Harada H, Kayamori K, Yamaguchi A, Sakamoto K. AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression PLoS ONE. 2020.02; 15 (2): e0222689. ( PubMed, DOI )

  169. Yamamoto Daisuke, Kayamori Kou, Sakamoto Kei, Tsuchiya Maiko, Ikeda Tohru, Harada Hiroyuki, Yoda Tetsuya, Watabe Tetsuro, Hara-Yokoyama Miki. 舌扁平上皮癌の浸潤先端部にみられる細胞内のクローディン1はリンパ節転移と関連している(Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis) Cancer Science. 2020.02; 111 (2): 700-712. ( ichushi )

  170. Nojima H, Homma H, Onozato Y, Kaida A, Harada H, Miura M. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells Exp Cell Res. 2020.01; 388 (2): 111720. ( PubMed, DOI )

  171. Kagifuku Y, Tohara H, Wakasugi Y, Susa C, Nakane A, Toyoshima M, Nakakuki K, Kabasawa Y, Harada H, Minakuchi S. What Factors Affect Changes in Body Composition and Swallowing Function in Patients Hospitalized for Oral Cancer Surgery? Clin Interv Aging. 2020.01; 15 1-7. ( PubMed, DOI )

  172. Oikawa Y, Michi Y, Tsushima F, Tomioka H, Mochizuki Y, Kugimoto T, Osako T, Nojima H, Yokokawa M, Kashima Y, Harada H. Management of retropharyngeal lymph node metastasis in oral cancer. Oral Oncology. 2019.12; 99 104471. ( PubMed, DOI )

  173. Homma H, Nojima H, Kaida A, Miura M. Induction of endomitosis-like event in HeLa cells following CHK1 inhibitor treatment Biochem Biophys Res Commun. . 2019.12;

  174. Kato Y, Takei J, Furusawa Y, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Takahashi M, Suzuki H, Yamada S, Kaneko MK. Epitope Mapping of Anti-Bear Podoplanin Monoclonal Antibody PMab-247. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.10; 38 (5): 230-233. ( PubMed, DOI )

  175. Takei J, Itai S, Harada H, Furusawa Y, Miwa T, Fukui M, Nakamura T, Sano M, Sayama Y, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Yamada S, Kaneko MK, Kato Y. Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.10; 38 (5): 213-219. ( PubMed, DOI )

  176. Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H.. Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism. 2019.09; 37 (5): 913-919. ( PubMed, DOI )

  177. Takei J, Furusawa Y, Yamada S, Nakamura T, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Kaneko MK, Kato Y. PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclon Antib Immunodiagn Immunother.. 2019.08; 38 (4): 171-174.

  178. Xia Y, Ohno T, Nishii N, Bhingare A, Tachinami H, Kashima Y, Nagai S, Saito H, Nakae S, Azuma M. Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model Biochemical and Biophysical Research Communications. 2019.08; 518 (2): 331-336. ( PubMed, DOI )

  179. Kato Y, Ohishi T, Yamada S, Itai S, Takei J, Sano M, Nakamura T, Harada H, Kawada M, Kaneko MK.. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-41-Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer Monoclon. Antib. Immunodiagn. Immunother.. 2019.08; 38 (4): 157-161.

  180. Atsushi Uesugi, Kaori Mochida, Hiroyuki Harada, Hideki Imai. Ossifying fibroma arising from the zygomatic arch: a case report Journal of Stomatology Oral and Maxillofacial Surgery. 2019.08;

  181. Okuyama K, Naruse T, Yutori H, Yanamoto S, Umeda M.. Oral surgery in patients with antiphospholipid syndrome. Journal of Oral Science. 2019.08; 61 (3): 386-390. ( PubMed, DOI )

  182. Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncol Lett. 2019.08; 8 (2): 1372-1380.

  183. Takei J, Furusawa Y, Yamada S, Nakamura T, Sayama Y, Sano M, Konnai S, Kobayashi A, Harada H, Kaneko MK, Kato Y. PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.08; 38 (4): 171-174. ( PubMed, DOI )

  184. Kato Y, Ohishi T, Yamada S, Itai S, Takei J, Sano M, Nakamura T, Harada H, Kawada M, Kaneko MK. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H(2)Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.08; 38 (4): 157-161. ( PubMed, DOI )

  185. Komiya R, Wada T, Tsushima F, Sakamoto K, Ikeda T, Yamaguchi A, Harada H, Uo M. Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw (MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis Journal pb Bone and Mineral Metabolism. 2019.07; 37 (4): 676-684.

  186. Yoshikazu F, Shinji Y, Takuro N, Masato S, Yusuke S, Shunsuke I,. A monoclonal antibody for the immunohistochemical analysis of goat podoplanin Heliyon. 2019.07; 5 (7): e02063.

  187. Komiya Ruri, Wada Takahiro, Tsushima Fumihiko, Sakamoto Kei, Ikeda Tohru, Yamagchi Akira, Harada Hiroyuki, Uo Motohiro. 誘導結合プラズマ原子発光分光法とシンクロトロン放射光X線蛍光解析を用いた薬剤関連性顎骨壊死(MRONJ)の腐骨における金属元素の定量と分布(Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw(MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis) Journal of Bone and Mineral Metabolism. 2019.07; 37 (4): 676-684. ( ichushi )

  188. Furusawa Y, Yamada S, Itai S, Nakamura T, Takei J, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin. Biochemistry and biophysics reports. 2019.07; 18 100631. ( PubMed, DOI )

  189. Furusawa Y, Yamada S, Itai S, Nakamura T, Yanaka M, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin. Biochemistry and biophysics reports. 2019.07; 18 100616. ( PubMed, DOI )

  190. Takei J, Itai S, Furusawa Y, Yamada S, Nakamura T, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Epitope mapping of anti-tiger podoplanin monoclonal antibody PMab-231. Monoclon Antib Immunodiagn Immunother.. 2019.06; 38 (3): 129-132.

  191. Kato Y, Furusawa Y, Itai S, Takei J, Nakamura T, Sano M, Harada H, Yamada S, Kaneko MK. . Establishment of an Anticetacean Podoplanin Monoclonal Antibody PMab-237 for Immunohistochemical Analysis. Monoclon Antib Immunodiagn Immunother.. 2019.06; 38 (3): 108-113.

  192. Kato Y, Furusawa Y, Itai S, Takei J, Nakamura T, Sano M, Harada H, Yamada S, Kaneko MK. Establishment of an Anticetacean Podoplanin Monoclonal Antibody PMab-237 for Immunohistochemical Analysis. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.06; 38 (3): 108-113. ( PubMed, DOI )

  193. Takei J, Itai S, Furusawa Y, Yamada S, Nakamura T, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Epitope Mapping of Anti-Tiger Podoplanin Monoclonal Antibody PMab-231. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.06; 38 (3): 129-132. ( PubMed, DOI )

  194. Suzuki N, Kuribayashi A, Sakamoto K, Sakamoto J, Nakamura S, Watanabe H, Harada H, Kurabayashi T. Diagnostic abilities of 3T MRI for assessing mandibular invasion of squamous cell carcinoma in the oral cavity: comparison with 64-row multidetector CT. Dento maxillo facial radiology. 2019.05; 48 (4): 20180311. ( PubMed, DOI )

  195. Mochizuki Y., Harada H., Oyama J., Sakamoto K., Michi Y., Kuroshima T., Kugimoto T.. Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia. Curr Probl Cancer. . 2019.05; 2019 May 23. pii: S0147-0272(18)30403-3.

  196. Minegishi Saki, Ohtani Susumu, Noritake Kanako, Funakoshi Takeshi, Ishii Namiko, Utsuno Hajime, Sakuma Ayaka, Saitoh Hisako, Yamaguchi Satoshi, Marukawa Eriko, Harada Hiroyuki, Uemura Koichi, Sakurada Koichi. 加熱により増加させたアスパラギン酸ラセミ化率に基づく年齢推定を目的とした象牙質標準試料の調製(Preparation of dentin standard samples for age estimation based on increased aspartic acid racemization rate by heating) Legal Medicine. 2019.05; 38 25-31. ( ichushi )

  197. Higuchi Y, Tsushima F, Sumikura K, Sato Y, Harada H, Kayamori K, Ikeda T.. Diagnosis and treatment of oral focal mucinosis: a case series. Journal of Medical Case Reports. 2019.04; 13(1) (108): Published online. ( DOI )

  198. Tachinami H, Nishii N, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Tomihara K, Noguchi M, Azuma M. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade. Oral Oncology. 2019.04; 91 21-28. ( PubMed, DOI )

  199. Okuyama K, Fukushima H, Naruse T, Yanamoto S, Tsuchihashi H, Umeda M.. CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis. Pathology and Oncology Research. 2019.04; 25 (2): 603-609. ( PubMed, DOI )

  200. Tomioka H, Mochizuki Y, Ohsako T, Hirai H, Shimamoto H, Harada H.. Buccinator and Mandibular Node Metastases in Oral Squamous Cell Carcinoma. Journal of oral and maxillofacial surgery. 2019.04; 77 (4): 867-873. ( PubMed, DOI )

  201. Furusawa Y, Kaneko MK, Nakamura T, Itai S, Fukui M, Harada H, Yamada S, Kato Y. Establishment of a monoclonal antibody PMab-231 for tiger podoplanin. Monoclon Antib Immunodiagn Immunother.. 2019.04; 38 (2): 89-95.

  202. Kaneko MK, Furusawa Y, Sano M, Itai S, Takei J, Harada H, Fukui M, Yamada S, Kato Y. Epitope mapping of the anti-horse podoplanin monoclonal antibody PMab-202. Monoclon Antib Immunodiagn Immunother.. 2019.04; 37 (5): 233-237.

  203. Furusawa Y, Yamada S, Itai S, Nakamura T, Takei J, Sano M, Harada H, Fukui M, Kaneko MK, Kato Y. Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin. Biochem Biophys Rep. 2019.04;

  204. Tomioka H, Mochizuki Y, Ohsako T, Hirai H, Shimamoto H, Harada H.. Buccinator and Mandibular Node Metastases in Oral Squamous Cell Carcinoma Journal of oral and maxillofacial surgery. 2019.04; 77 (4): 867-873. ( DOI )

  205. Kishimoto Yo, Harada Hiroyuki, Funakoshi Makiko, Miyamoto Shin-ichi, Suehiro Atsushi, Kitamura Morimasa, Muto Manabu, Tateya Ichiro, Omori Koichi. 高齢患者に対する内視鏡下咽喉頭手術(Endoscopic laryngo-pharyngeal surgery for elderly patients) Auris・Nasus・Larynx. 2019.04; 46 (2): 279-284. ( ichushi )

  206. Yamada S, Kaneko MK, Furusawa Y, Itai S, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Koyanagi M, Fukui M, Harada H, Kato Y. Anti-Bovine Podoplanin Monoclonal Antibody PMab-44 Detects Goat Podoplanin in Immunohistochemistry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.04; 38 (2): 96-99. ( PubMed, DOI )

  207. Kaneko MK, Furusawa Y, Sano M, Itai S, Takei J, Harada H, Fukui M, Yamada S, Kato Y. Epitope Mapping of the Antihorse Podoplanin Monoclonal Antibody PMab-202. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.04; 38 (2): 79-84. ( PubMed, DOI )

  208. Furusawa Y, Kaneko MK, Nakamura T, Itai S, Fukui M, Harada H, Yamada S, Kato Y. Establishment of a Monoclonal Antibody PMab-231 for Tiger Podoplanin. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.04; 38 (2): 89-95. ( PubMed, DOI )

  209. Higuchi Y, Tsushima F, Sumikura K, Sato Y, Harada H, Kayamori K, Ikeda T. Diagnosis and treatment of oral focal mucinosis: a case series. Journal of medical case reports. 2019.04; 13 (1): 108. ( PubMed, DOI )

  210. Ishida S, Kayamori K, Sakamoto K, Yukimori A, Kugimoto T, Harada H, Ikeda T.. Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma. Pathol Int.. 2019.02;

  211. Yoshikazu F, Shinji Y, Shunsuke I, Takuro N, Miyuki Y, Masato S, Hiroyuki H, Masato F, Mika K.K, Yukinari K. A monoclonal antibody for the immunohistochemical analysis of horse podoplanin Biochem Biophys Rep.. 2019.02; (18): 100616.

  212. Yoshikazu F, Shinji Y, Shunsuke I, Masato S, Takuro N, Miyuki Y, masato F, Hiroyuki H, Takuya M, Yusuke S, Masaki T, Mika K.K, Yukinari K. A Monoclonal Antibody Against Pig Podoplanin Monoclon. Antib. Immunodiagn. Immunother.. 2019.02; 38 (1): 30-36.

  213. Ishida Shoko, Kayamori Kou, Sakamoto Kei, Yukimori Akane, Kugimoto Takuma, Harada Hiroyuki, Ikeda Tohru. Alpha-L-fucosidase-1は扁平上皮癌と粘表皮癌を識別する診断マーカーである(Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma) Pathology International. 2019.02; 69 (2): 76-85. ( ichushi )

  214. Furusawa Y, Yamada S, Itai S, Sano M, Nakamura T, Yanaka M, Fukui M, Harada H, Mizuno T, Sakai Y, Takasu M, Kaneko MK, Kato Y. PMab-210: A Monoclonal Antibody Against Pig Podoplanin. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.02; 38 (1): 30-36. ( PubMed, DOI )

  215. Kato Y, Yamada S, Furusawa Y, Itai S, Nakamura T, Yanaka M, Sano M, Harada H, Fukui M, Kaneko MK. PMab-213: A Monoclonal Antibody for Immunohistochemical Analysis Against Pig Podoplanin. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2019.02; 38 (1): 18-24. ( PubMed, DOI )

  216. Fukuda S, Akiyama M, Harada H, Nakahama KI.. Effect of gap junction-mediated intercellular communication on TGF-β induced epithelial-to-mesenchymal transition. Biochem Biophys Res Commun.. 2019.01; 508 (3): 928-933. ( DOI )

  217. Takada Kaho, Kuroshima Takeshi, Shimamoto Hiroaki, Ohsako Toshimitsu, Kayamori Kou, Ikeda Tohru, Harada Hiroyuki. Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature WORLD JOURNAL OF SURGICAL ONCOLOGY. 2019.01; 17 (1): 13. ( PubMed, DOI )

  218. Shimizu R, Tanaka K, Oikawa Y, Tomioka H, Kayamori K, Ikeda T, Yoshioka T, Ebihara A, Harada H. Epithelioid cell granuloma with caseating necrosis possibly caused by periapical periodontitis: a case report. Journal of Medical Case Reports.. 2018.12; 12 (1): 365-370. ( PubMed, DOI )

  219. Takahashi Y, Tanaka K, Hirai H, Marukawa E, Izumo T, Harada H. Appropriate surgical margin for odontogenic myxoma: a review of 12 cases. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2018.11; 126 (5): 404-408. ( DOI )

  220. Furusawa Y, Yamada S, Itai S, Sano M, Nakamura T, Yanaka M, Handa S, Mizuno T, Maeda K, Fukui M, Harada H, Kaneko MK, Kato Y. Establishment of Monoclonal Antibody PMab-202 against Horse Podoplanin Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11; 37 (5): 233-237. ( PubMed, DOI )

  221. Yamada S, Itai S, Furusawa Y, Sano M, NakamuraT, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Mizuno T, Sakai Y, Ogasawara S, Murata T, Uchida H, Tahara H, Kaneko MK, Kato Y. Detection of tiger podoplanin using the anti-cat podoplanin monoclonal antibody PMab-52 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11; 37 (5): 224-228. ( PubMed, DOI )

  222. Mochizuki Y, Harada H, Yokokawa M, Kinoshita N, Kubota K, Okado T, Fukayama H. Oral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases. BMC Oral Health. 2018.10; 18 (1): 166-175. ( PubMed, DOI )

  223. Yamada I, Yoshino N, Hikishima K, Sakamoto J, Yokokawa M, Oikawa Y, Harada H, Kurabayashi T, Saida Y, Tateishi U, Yukimori A, Izumo T, Asahina S. Oral carcinoma: Clinical evaluation using diffusion kurtosis imaging and its correlation with histopathologic findings Magnetic Resonance Imaging. 2018.09; 51 69-78. ( PubMed, DOI )

  224. Kaneko MK, Yamada S, Itai S, Furusawa S, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Kato Y. Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome Xlinked monoclonal antibody AMab-6 Biochem Biophys Rep. 2018.09; 15 76-80. ( PubMed, DOI )

  225. Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible Oral radiology. 2018.09; 34 (3): 257-261. ( DOI )

  226. Itai S, Yamada S, Kaneko MK, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Furusawa Y, Fukui M, Ohishi T, Kawada M, Harada H, Kato Y. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2 Biochem Biophys Rep. 2018.09; 15 93-96. ( PubMed, DOI )

  227. Ngamsom Supak, Nakamura Shin, Kabasawa Yuji, Harada Hiroyuki, Tohyama Rei, Kurabayashi Tohru. 下顎骨内に発生した外傷性神経腫の画像所見(Imaging findings of intraosseous traumatic neuroma of the mandible) Oral Radiology. 2018.09; 34 (3): 257-261. ( ichushi )

  228. Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible. Oral radiology. 2018.09; 34 (3): 257-261. ( PubMed, DOI )

  229. Matsui T, Okada T, Kawada K, Okuda m, Ogo T, Nakajima Y, Kume Y, Ryotokuji T, Hoshino A, Tokairin Y, Michi Y, Harada H, Nakajima Y, Kawano T. Detection of second primary malignancies of the esophagus and hypophraynx in oral squamous cell carcinoma patients Laryngoscope Investigative Otolaryngology. 2018.08; 3 (4): 263-267. ( DOI )

  230. Yamaga E, Toriihara A, Nakamura S, Asai S, Fujioka T, Yoshimura R, Michi Y, Harada H, Tateishi U. Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( DOI )

  231. Shimada Y, Kawasaki Y, Tayama M, Kindaichi J, Maruoka Y. A case of central odontogenic fibroma of the mandible in a nevoid basal cell carcinoma syndrome patient Oral Science International. 2018.07; 15 (2): 61-67. ( DOI )

  232. Yamaga Emi, Toriihara Akira, Nakamura Shin, Asai Sakurako, Fujioka Tomoyuki, Yoshimura Ryoichi, Michi Yasuyuki, Harada Hiroyuki, Tateishi Ukihide. 2-deoxy-2-[18F]fluoro-D-glucoseを用いたPET/CTによる早期口腔扁平上皮癌(cT1-2N0M0)評価の臨床有用性(Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma(cT1-2NOMO)) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( ichushi )

  233. Yamada S, Kaneko MK, Itai S, Chang YW, Nakamura T, Yanaka M, Ogasawara S, Murata T, Uchida H, Tahara H, Harada H, Kato Y. Epitope Mapping of Monoclonal Antibody PMab-48 against Dog Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.06; 37 (3): 162-165. ( PubMed, DOI )

  234. Ohata Y, Kayamori K, Yukimori A, Sumikura K, Ohsako T, Harada H, Sakamoto K, Ikeda T. A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation. Pathology International. 2018.05; 68 (5): 307-312. ( PubMed, DOI )

  235. Kaneko MK, Yamada S, Itai S, Chang YW, Nakamura T, Yanaka M, Harada H, Suzuki H, Kato Y. Elucidation of The TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05; 38 (3): 101-103. ( PubMed, DOI )

  236. Miyazaki H, Ohshiro T, Romeo U, Noguchi T, Maruoka Y, Gaimari G, Tomov G, Wada Y, Tanaka K, Ohshiro T, Asamura S. Retrospective Study on Laser Treatment of Oral Vascular Lesions Using the "Leopard Technique": The Multiple Spot Irradiation Technique with a Single-Pulsed Wave Photomed Laser Surgery. 2018.05; 36 (6): 320-325. ( PubMed )

  237. Furusawa Y, Yamada Y, Itai S, Nakamura T, Fukui M, Harada H, Kaneko MK, Kato Y. Elucidation of critical epitope mapping of anti-rat podoplanin monoclonal antibody PMab-2 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05; 37 (4): 188-193. ( PubMed, DOI )

  238. Ohata Yae, Kayamori Kou, Yukimori Akane, Sumikura Kanako, Ohsako Toshimitsu, Harada Hiroyuki, Sakamoto Kei, Ikeda Tohru. CTNNB1変異を伴う幻影細胞性歯原性癌と象牙質形成性幻影細胞腫間に分類された病変(A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation) Pathology International. 2018.05; 68 (5): 307-312. ( ichushi )

  239. Itai S, Ohishi T, Kaneko MK, Yamada S, Abe S, Nakamura T, Yanaka M, Chang YW, Ohba S, Nishioka Y, Kawada M, Harada H, Kato Y. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma. Oncotarget. 2018.04; 9 (32): 22480-22497. ( PubMed, DOI )

  240. Sato M, Harada H, Nagata C, Suzuki K. A case of Ectomesenchymal Chondromyxoid Tumor on the tongue Journal of Oral and Maxillofacial Surgery, Medicine. 2018.03; 30 (2): 134-137. ( DOI )

  241. Nishii N, Tachinami H, Kondo Y, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Lau W, Harada H, Azuma M. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. Oncotarget. 2018.03; 9 (17): 13301-13312. ( PubMed, DOI )

  242. Ando Kentaro, Nakamura Yuji, Hagiwara-Nagasawa Mihoko, Harada Hiroyuki, Miyamoto Hiroyoshi, Inamura Naoki, Takagi Kan, Goto Ai, Chiba Koki, Lubna Nur Jaharat, Izumi-Nakaseko Hiroko, Naito Atsuhiko T., Sugiyama Atsushi. テルフェナジンの薬力学的および薬物動態学的プロファイルの変動ならびにその活性誘導体であるフェキソフェナジンのトルサード・ド・ポワント誘導リスクについて検討するための、ハロタン麻酔イヌを対象としたクロスオーバー試験によるテルフェナジンとフェキソフェナジンの電気薬理学的作用の比較(Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine) The Journal of Toxicological Sciences. 2018.03; 43 (1-3): 183-192. ( ichushi )

  243. Sato Masaru, Harada Hiroyuki, Nagata Chigusa, Suzuki Keiko. 舌のectomesenchymal chondromyxoid tumorの1例(A case of ectomesenchymal chondromyxoid tumor of the tongue) Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2018.03; 30 (2): 134-137. ( ichushi )

  244. Ohata Y, Tsuchiya M, Hirai H, Yamaguchi S, Akashi T, Sakamoto K, Yamaguchi A, Ikeda T, Kayamori K. Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma PLoS One. 2018.02; e0191865.

  245. Jiaranuchart S, Kaida A, Onozato Y, Harada H, Miura M. DNA damage response following X-irradiation in oral cancer lines HSC3 and HSC4 Archives of Oral Biology. 2018.02; 90 1-8. ( PubMed, DOI )

  246. Kuroshima T, Wada M, Sato T, Takano M, and Makino S. G-CSF producing oral carcinoma with diffuse uptake of FDG in the bone marrow: A case report Oncology Letters. 2018.01; 15 (1): 1241-1245.

  247. Nishii N, Tachinami H, Kondo Y, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Lau W, Harada H, Azuma M. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dend+E11:AB11ritic cell modification and overcomes resistance to PD-L1 blockade therapy Oncotarget. 2018.01; 9 13301-13312. ( DOI )

  248. Takemoto T, Kabasawa Y, Higuchi Y, Tabata Y, Aoki K, Tamura Y, Harada H. Combination of the RANKL-binding peptide W9 and bFGF induces ectopic bone regeneration in the rat calvarial defect mode Dental, Oral and Craniofacial Research. 2017.12; 4 (3): 2-7. ( DOI )

  249. Harada H, Suehiro S, Murakami D, Nakahara R, Ujihara T, Shimizu T, Miyama Y, Katsuyama Y, Hayasaka K, Tounou S. Clinical impact of prophylactic clip closure of mucosal defects after colorectal endoscopic submucosal dissection. Endoscopy international open. 2017.12; 5 (12): E1165-E1171. ( PubMed, DOI )

  250. Harada Hiroyuki, Shinohara Shogo, Takebayashi Shinji, Kikuchi Masahiro, Fujiwara Keizo, Michida Tetsuhiko, Yamamoto Ryosuke, Hayashi Kazuki, Saida Koji, Naito Yasushi. アルコール摂取後の顔面潮紅は上部消化管癌の同時性または異時性リスクが高いことの予測因子である(Facial flushing after alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper gastrointestinal tract) Japanese Journal of Clinical Oncology. 2017.12; 47 (12): 1123-1128. ( ichushi )

  251. Itai S, Yamada S, Kaneko MK, Harada H, Kagawa Y, Konnai S, Kato Y. Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.12; 36 (6): 243-250. ( PubMed, DOI )

  252. マハムド・エルバシュティ , アメル・アスウェヘリー , 服部 麻里子, 隅田 由香, 道 泰之, 鵜澤 成一, 山口 聡, 原田 浩之, 谷口 尚. 上顎切除患者に対する顎顔面補綴治療上の考慮事項に関する外科医の意識調査(Surgeons' Awareness of the Considerations for Prosthetic Rehabilitation in Maxillectomy Patients) 顎顔面補綴. 2017.12; 40 (2): 28-36. ( ichushi )

  253. Itai S, Yamada S, Kaneko MK, Chang YW, Harada H, Kato Y. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.12; 36 (6): 272-281. ( PubMed, DOI )

  254. Yamada S, Itai S, Nakamura T, Chang YW, Harada H, Suzuki H, Kaneko MK, Kato Y. Establishment of H(2)Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.12; 36 (6): 287-290. ( PubMed, DOI )

  255. Itai S, Yamada S, Kaneko MK, Harada H, Kagawa Y, Konnai S, Kato Y. Expression of cat podoplanin in feline squamous cell carcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11; ( DOI )

  256. Yamada S, Itai S, Nakamura T, Chang YW, Harada H, Suzuki H, Kaneko MK, Kato Y. Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11; ( DOI )

  257. Itai S, Yamada S, Kaneko MK, Chang YW, Harada, H, Kato Y. Establishment of EMab-134, a sensitive and specific anti-epidermal growth factor receptor monoclonal antibody for detecting squamous cell carcinoma cells of the oral cavity Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11; ( DOI )

  258. Ohata Y, Tatsuzawa A, Ohyama Y, Ichikawa A, Mochizuki Y, Ishibashi S, Itakura Y, Sakamoto K, Ikeda T, Kitagawa M, Yamamoto K. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer Human Pathology. 2017.11; 69 129-139. ( DOI )

  259. Itai S, Kaneko MK, Fujii Y, Yamada S, Nakamura T, Yanaka M, Saidoh N, Handa S, Chang YW, Suzuki H, Harada H, Kato Y. Development of EMab-51, a Sensitive and Specific Anti-EGFR Monoclonal Antibody in Western Blot and Immunohistochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10; 36 (5): 214-219. ( PubMed, DOI )

  260. Yamagata Y, Tomioka H, Sakamoto K, Sato K, Harada H, Ikeda T, Kayamori K. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma J Oral Maxillofac Surg. 2017.10; 75 (10): 2144-2153. ( DOI )

  261. Yamada S, Itai S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Harada H, Kagawa Y, Ichii O, Konnai S, Kaneko MK, Kato Y. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10; ( DOI )

  262. Itai S, Yamada S, Kaneko MK, Harada H, Kato Y. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10; ( DOI )

  263. Itai S, Fujii Y, Nakamura T, Chang YW, Yanaka M, Saidoh N, Handa S, Suzuki H, Harada H, Yamada S, Kaneko MK, Kato Y. Establishment of CMab-43, a Sensitive and Specific Anti-CD133 Monoclonal Antibody, for Immunohistochemistry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.10; 36 (5): 231-235. ( PubMed, DOI )

  264. Itai S, Yamada S, Kaneko MK, Harada H, Kato Y. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.10; 36 (5): 220-223. ( PubMed, DOI )

  265. Yamada S, Itai S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Harada H, Kagawa Y, Ichii O, Konnai S, Kaneko MK, Kato Y. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.10; 36 (5): 224-230. ( PubMed, DOI )

  266. Ngansom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible Oral Radiology. 2017.09;

  267. Hirai H, Tomioka H, Mochizuki Y, Oikawa Y, Tsushima F, Harada H. Clinical Course of Oral Squamous Cell Carcinoma in Patients on Immunosuppressant and Glucocorticoid Therapy J Oral Maxillofac Surg. 2017.09; 75 (9): 1980-1986. ( PubMed, DOI )

  268. Takahara N, Nakagawa S, Sumikura K, Kabasawa Y, Sakamoto I, Harada H. Association of TMJ pain according to magnetic resonance imaging findings in TMD patients J Oral Maxillofac Surg. 2017.09; 75 (9): 1848-1855. ( PubMed, DOI )

  269. Itai S, Fujii Y, Kaneko MK, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Takahashi M, Suzuki H, Harada H, Kato Y. H2Mab-77 is a sensitive and specific anti-HER2 monoclonal antibody against breast cancer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08; ( DOI )

  270. Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Mizuno S, Satoh E, Sakane F, Okada N, Taketomi A, Honma R, Nakamura T, Saidoh N, Yanaka M, Itai S, Handa S, Chang YW, Yamada S, Kaneko MK, Kato Y, Goto K. DaMab-2: Anti-Human DGK Monoclonal Antibody for immunocytochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08; ( DOI )

  271. Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y. Anti-Podocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08; ( DOI )

  272. Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.08; 36 (4): 157-162. ( PubMed, DOI )

  273. Itai S, Fujii Y, Kaneko MK, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Takahashi M, Suzuki H, Harada H, Kato Y. H(2)Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017.08; 36 (4): 143-148. ( PubMed, DOI )

  274. Shimamoto H, Oikawa Y, Osako T, Hirai H, Mochizuki Y, Tanaka K, Tomioka H, Harada H. Neck failure after elective neck dissection in patients with oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol. 2017.07; 124 (1): 32-36. ( DOI )

  275. Hihara H, Kanetaka H, Kanno A, Koeda S, Nakasato N, Kawashima R, Sasaki K. Evaluating age-related change in lip somatosensation using somatosensory evoked magnetic fields PLOS One. 2017.06; 12 (6):

  276. Mochizuki Y, Harada H, Shimamoto H, Tomioka H, Hirai H. Multiple Free Flap Reconstructions of Head and Neck Defects Due to Oral Cancer Plast Reconstr Surg Glob Open. 2017.06; 5 (6): e1337. ( PubMed, DOI )

  277. Yukimori A, Oikawa Y, Morita KI, Nguyen CTK, Harada H, Yamaguchi S, KayamoriK, Yamaguchi A, Ikeda T, Sakamoto K. Genetic basis of calcifying cysticodontogenic tumors PLoS One. 2017.06; 12 (6): e0180224. ( PubMed, DOI )

  278. Shinohara Shogo, Suehiro Atsushi, Kikuchi Masahiro, Harada Hiroyuki, Kishimoto Ippei, Imai Yukihiro. 喉頭の再発扁平上皮癌と共存した類腱腫の一症例(A case of desmoid tumor co-existing with recurrent squamous cell carcinoma in the larynx) Auris・Nasus・Larynx. 2017.06; 44 (3): 365-369. ( ichushi )

  279. Harada H, Suehiro S, Murakami D, Shimizu T, Nakahara R, Katsuyama Y, Miyama Y, Tounou S, Hayasaka K. Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study. Endoscopy international open. 2017.05; 5 (5): E348-E353. ( PubMed, DOI )

  280. Onozato Y, Kaida A, Harada H, Miura M. Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids Cancer Science. 2017.04;

  281. Onozato Yusuke, Kaida Atsushi, Harada Hiroyuki, Miura Masahiko. 多細胞性腫瘍スフェロイドとして生育した静止細胞および増殖細胞の放射線感受性(Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids) Cancer Science. 2017.04; 108 (4): 704-712. ( ichushi )

  282. Nguyen CT,Okamura T, Morita K,Yamaguchi S,Harada H,Miki Y,Izumo T,Kayamori K,Yamaguchi A,Sakamoto K. LAMC2 is a predictive marker for the malignant progression of leukoplakia Journal of Oral Pathology and Medicine. 2017.03; 46 (3): 223-231. ( PubMed, DOI )

  283. Oikawa Y,Morita K,Kayamori K,Tanimoto K,Sakamoto K,Katoh H,Ishikawa S,Inazawa J,Harada H. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma Cancer Science. 2017.02; 108 (2): 256-266.

  284. Shimada Y, Nakagawa Y, Ide K, Sato I, Hagiwara S, Yamada H, Kawasaki Y, Maruoka Y. Clinical importance of elimination of potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy. Support Care Cancer. 2017.02; ( DOI )

  285. Oikawa Yu, Morita Kei-ichi, Kayamori Kou, Tanimoto Kousuke, Sakamoto Kei, Katoh Hiroto, Ishikawa Shumpei, Inazawa Johji, Harada Hiroyuki. 口腔扁平上皮癌患者では受容体チロシンキナーゼの増幅により遠隔転移が予測される(Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma) Cancer Science. 2017.02; 108 (2): 256-266. ( ichushi )

  286. Kaneko MK,Nakamura T,Honma R,Ogasawara S,Fujii Y,Abe S,Takagi M,Harada H,Suzuki H,Nishioka Y,Kato Y. Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin using glycan-deficient cell lines generated by CRISPR/Cas and TALEN Cancer Medicine. 2017.01; 6 (2): 382-396. ( PubMed, DOI )

  287. Takahara N,Kabasawa Y,Sato M,Tetsumura A,Kurabayashi T,Omura K. MRI Changes of temporomandibular joint following mandibular setback using sagittal split ramus osteotomy with rigid fixation The Journal of Craniomandibular & Sleep Practice. 2017.01; 35 (11): 38-45. ( DOI )

  288. Lam PD, Kuribayashi A, Sakamoto J, Nakamura S, Harada H, Kurabayashi T. Imaging findings of childhood B-cell lymphoblastic lymphoma in the mental region: a case report. Dentomaxillofacial Radiology. 2017; 46 (3): 20160313. ( PubMed, DOI )

  289. Marukawa E,Tamai M,Takahashi Y,Hatakeyama I,Sato M,Higuchi Y,Kakidachi H,Taniguchi H,Sakamoto T,Honda J,Omura K,Harada H. Comparison of magnesium alloys and poly-l-lactide screws as degradable implants in a canine fracture model Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2016.10; 104 (7): 1282-1289.

  290. Shimada Y,Maruoka Y,Yamaji I,Kawai S. Non-syndromic familial keratocystic odontogenic tumour: a rare case report in Japanese identical twins. J Clin Diagn Res. 2016.08; 10 (8): ZD28-ZD30.

  291. Macedo R,Rochefort J,Guillot-Delost M,Tanaka K,Le Moignic A,Noizat C,Baillou C,Mateo V,Carpentier AF,Tartour E,Bertolus C,Bellier B,Lescaille G,Lemoine FM. Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles Oncoimmunology. 2016.07; 5 (7): e1164363. ( DOI )

  292. Tohyama R,Kayamori K,Sato K,Hamagaki M,Sakamoto K,Yasuda H,Yamaguchi A. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL Journal of Oral Pathology & Medicine. 2016.05; 45 (5): 356-364.

  293. Kohmoto T,Tsuji A,Morita K,Naruto T,Masuda K,Kashimada K,Enomoto K,Morio T,Harada H,Imoto I. A novel COL11A1 missense mutation in siblings with non-ocular Stickler syndrome Human Genome Variation. 2016.04; 2016 (3): 16003. ( DOI )

  294. Kayamori K,Katsube K,Sakamoto K,Ohyama Y,Hirai H,Yukimori A,Ohata Y,Akashi T,Saitoh M,Harada K,Harada H,Yamaguchi A. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma PLoS One. 2016.04; 11 (4): e0154112. ( DOI )

  295. Shirakawa J,Harada H,Noda M,Ezura Y. PTH-Induced Osteoblast Proliferation Requires Upregulation of the Ubiquitin-Specific Peptidase 2 (Usp2) Expression Calcified Tissue International. 2016.03; 98 (3): 306-315.

  296. Oda S,Nozawa T,Nozawa-Minowa A,Tanaka M,Aikawa C,Harada H,Nakagawa I. Golgi-Resident GTPase Rab30 Promotes the Biogenesis of Pathogen-Containing Autophagosomes PLoS One. 2016.01; 11 (1): e0147061. ( DOI )

  297. Kondo Y,Ohno T,Nishii N,Harada K,Yagita H,Azuma M. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma Oral Oncology. 2016; 57 54-60.

  298. Mochizuki Y,Tomioka H,Tsushima F,Shimamoto H,Oikawa Y,Harada H. Clinical evaluation of the coverage of open wounds in the oral surgical field with a polyglycolic acid sheet and a fibrin glue spray and coverage with split thickness skin grafting Annals Maxillofacial Surgery. 2016; 6 (2): 228-234.

  299. Kato Y,Ogasawara S,Oki H,Honma R,Takagi M,Fujii Y,Nakamura T,Saidoh N,Kanno H,Umetsu M,Kamata S,Kubo H,Yamada M,Sawa Y,Morita K,Harada H,Suzuki H,Kaneko MK. Novel Monoclonal Antibody LpMab-17 Developed by CasMab Technology Distinguishes Human Podoplanin from Monkey Podoplanin Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2016; 2 (35): 109-116.

  300. Dilruba Aktar,Tomioka H,Hirai H,Oikawa Y,Mochizuki Y,Shimamoto H,Harada H. Value of real-time tissue elastography for squamous cell carcinoma of the tongue Dental,Oral and Craniofacial Research. 2016; 2 (6): 371-375.

  301. Ohata Y,Tohyama R,Kayamori K,Shimamoto H,Hirota Y,Harada H,Izumo T,Sakamoto K. A rare cancer of the tongue that demonstrated unusual histology and immunohistochemical phenotype: case report International Dentistry Scientific Meeting 2016/UI Proceedings on Health and Medicine. 2016; 1 (1): 172-175. ( DOI )

  302. Masanori Kudoh, Ken Omura, Arata Satsukawa, Koshi Matsumoto, Takahide Taguchi, Hiroyuki Harada, Yoshimasa Ishii. Symmetric Lipomatosis Arising in the Tongue Presenting as Macroglossia and Articulatory Disorder Case Reports in Otolaryngology. 2016; (2016): ( DOI )

  303. Masaru S,Morita K,Kabasawa Y,Harada H. Bilateral nasolabial cysts: a case report Jounal of Medical case Reports. 2016; 10 246. ( DOI )

  304. Kudoh M, Harada H, Sato Y, Omura K, Ishii Y. Massive odontoameloblastoma arising in the maxilla: a case report. J Medical Case Rep. 2015.12; 9 278. ( PubMed, DOI )

  305. Fukuda S, Hayashi R, Nishimura Y, Nakamizo M, Ota Y, Chazono H , Nakamura K, Harada H, Fujimoto Y, Yoshimoto S. Report of fead and neck cancer registry of Japan clinical statistics of registered patients, 2013. Japanese Journal of Head and Neck Cancer. 2015.11; 41 (supplement):

  306. Morita K, Naruto T, Tanimoto K, Yasukawa C, Oikawa Y, Masuda K, Imoto I, Inazawa J, Omura K, Harada H. Simultaneous detection of both single nucleotide variations and copy number alterations by next-generation sequencing in gorlin syndrome. PLOS One. 2015.11; 10 (11): e0140480. ( PubMed, DOI )

  307. Kuribayashi Y, Tsushima F, Morita K, Matsumoto K, Sakurai J, Uesugi A, Sato K, Oda S, Sakamoto K, Harada H. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015.11; 51 (11): 1020-1025. ( PubMed, DOI )

  308. Tsushima F, Sakurai J, Harada H. A case of upper gingiva carcinoma with chronic graft-versus-host disease after allogenic bone marrow transplantation. Aust Dent J. 2015.09; 60 (3): 404-407.

  309. Kudo M, Harada H, Matsumoto K, Sato Y, Omura K, Ishii Y. Massive neurilemoma of the hard plate in which preoperative diagnosis was difficult. Case Rep Surg. 2015.08; 2015 638025. ( DOI )

  310. Mochizuki Y, Harada H, Sakamoto K, Kayamori K, Nakamura S, Ikuta M, Kabasawa Y, Marukawa E, Shimamoto H, Tushima F, Omura K. Malignant lymphoma with initial symptoms in the mandibular region. J Cancer Ther. 2015.07; 6 (7): 554-565.

  311. Tomioka H, Kaneoya A, Mochizuki Y, Harada H. Primary diffuse large B-cell lymphoma arising in the tongue accompanied by ataxia-telangiectasia: a case report. J Clin Diagn Res. 2015.06; 9 (6): ZD25-ZD27. ( PubMed, DOI )

  312. Mochizuki Y, Harada H, Ikuta M, Shimamoto H, Tomioka H, Tanaka K, Hirai H, Omura K. Clinical characteristics of multiple primary carcinomas of the oral cavity. Oral Oncol. 2015.02; 51 (2): 182-189.

  313. Harada H, Omura K.. Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: Phase I trial. J Exp Clin Cancer Res.. 2010; 20 (29): 33.

  314. H Harada, K Omura.. Metastasis of oral cancer to the parotid node. Eur J Surg Oncol. 2009; 35 (8): 890-894.

  315. Hiroyuki Harada, Ken Omura, Yusuke Nakajima, Shogo Hasegawa and Seiki Mogi.. Cyclin B1 is useful to predict occult cervical lymph node metastasis in tongue carcinoma. J Exp Clin Cancer Res. 2006; 25 (3): 351-356.

  316. Hiroyuki Harada, Ken Omura, Yosuke Takeuchi.. Patency and caliber of the internal jugular vein after neck dissection. Auris Nasus Larynx. 2003; 30 (3): 269-272.

  317. 1) Hiroyuki Harada, Shuichi Takinami, Shujiroh Makino, Hideaki Kitada, Tomomi Yamashita, Ken-ichi Notani, Hiroshi Fukuda, Motoyasu Nakamura.. Three-phase bone scintigraphy and viability of vascularized bone grafts for mandibular reconstruction. Int J of Oral & Maxillofac Surg. 2000; 29 (4): 280-284.

▼display all

Conference Activities & Talks 【 display / non-display

  1. Marukawa E, Hatakeyama I, Takahashi Y, Omura K. Effects of Platelet-Poor Plasma, Platelet-Rich Plasma, and Platelet-Rich Fibrin on healing of extraction sockets with buccal dehiscence in dogs. 23rd The European Association for Osseointegration September 25-27, 2014 2014.09.25 Rome, Italy

  2. Tanaka K, Taguchi T, Mochizuki H, Tomioka H, Shimamoto H, Ikuta M, Harada H, Bertolus C, Goudot P, Omura K. A clinical study on 74 cases of salivary gland carcinoma. The 22nd Congress of the European Association for Cranio-Maxillo-Facial Surgery September 23-26, 2014 2014.09.23 Prague

  3. Kudoh M, Harada H, Sato Y, Omura K, Ishii Y. Massive odontoameloblastoma arising in the maxilla. 96th AAOMS Annual Meeting, Scientific Sessions and Exhibition September 8-13, 2014 2014.09.08 Honolulu

  4. Marukawa E, Tamai M, Takahashi Y, Hatakeyama I, Sato M, Higuchi Y, Harada H, Omura K. Comparison of magnesium alloy and poly-L-lactide screws as degradable implant in canine fracture model. 6th Symposium on Biodegradable Metals.August 24-29, 2014 2014.08.24 Maratea, Italy.

  5. Oda S, Sakurai J, Tsushima F, Sato M, Uesugi A, Matsumoto K, Omura K. The Long-Term Outcome Of OLP, Patterns of Remission and Relapse. 2014 Joint Oral Medicine Meeting April 9-12, 2014 2014.04.09 Orland

  6. Matsumoto K, Tsushima F, Sakurai J, Sato M, Uesugi A, Oda S, Omura K. Oral lichen planus: a retrospective study of 416 Japanese patients. 2014 Joint Oral Medicine Meeting April 9-12, 2014 2014.04.09 Orland

  7. Tanaka M, Harada H, Kimura H. The role of H3K9me3 in oral squamous cell carcinoma migration. 第45回日本分子生物学会年会 2022.11.30 千葉市

  8. 釘本 琢磨, 清水 六花, 西井 直人, 大迫 利光, 及川 悠, 黒嶋 雄志, 平井 秀明, 富岡 寛文, 道 泰之, 栢森 高, 池田 通, 原田 浩之. 口腔扁平上皮癌におけるBucco-mandibular space進展例の臨床病理学的検討. 日本癌治療学会学術集会抄録集 2022.10.01

  9. 西井 直人, 高川 祐希, 高橋 幸伸, 津島 文彦, 弘津 陽介, 小山 敏雄, 小俣 政男, 原田 浩之. 口腔扁平苔癬におけるTCRレパトア解析. 日本癌治療学会学術集会抄録集 2022.10.01

  10. 清水六花, 田中美和, 本目みずき, 粂川昂平, 山崎ゆかり, 山下亨子, 大里元美, 丸山玲緒, 中村卓郎. HEY1-NCOA2はRunx2との相互作用を介して間葉性軟骨肉腫を発生と悪性化を誘導する. 第81回日本癌学会学術総会 2022.09.29 横浜市

  11. 時崎詩織, 井上カタジナアンナ, 高橋和樹, 松本武久, 白水美香子, 原田浩之, 渡部徹郎. 全てのTGF-βアイソフォームを標的とした新規Fc融合タンパク質製剤の開発. 第81回日本癌学会学術総会 2022.09.29 横浜市

  12. ダルンパン・ピッサチャー , 西井 直人, 津島 文彦, 原田 浩之, 東 みゆき. 舌扁平上皮癌の臨床および免疫病理プロファイルの包括的解析(Comprehensive analyses between clinical outcome and immunopathological profiles in tongue SCC). 日本癌学会総会記事 2022.09.01

  13. 時崎 詩織, 井上 カタジナアンナ, 高橋 和樹, 松本 武久, 白水 美香子, 原田 浩之, 渡部 徹郎. 全てのTGF-βアイソフォームを標的とした新規Fc融合タンパク質製剤の開発(Development of novel Fc chimeric receptor targeting all transforming growth factor-β isoforms). 日本癌学会総会記事 2022.09.01

  14. Okuyama K, Yanamoto S. TMEM16A as a therapeutic target for Head and Neck Cancer . 8th World Congress of the International Academy of Oral Oncology 2022.06.23 Chicago, Illinois, USA

  15. Ami Kuribayashi, Junichiro Sakamoto, Kou Kayamori, Sakurako Kawashima, Hiroyuki Harada, Tohru Kurabayashi. A case of liposarcoma of the floor of the mouth. The 13th Asian Congress of Oral and Maxillo-Facial Radiology 2022.06.03

  16. Tsushima F, Harada H. Clinical evaluation of malignant transformation in oral leukoplakia and oral lichen planus. 第34回台湾口腔顎顔面外科学会・学術大会 2022.03.13 台北

  17. Pissacha Daroonpan, 加島義久, 濱垣美和子, 西井直人, 津島文彦, 原田浩之, 池田 通, 東みゆき. マルチプレックス免疫組織染色による舌扁平上皮癌の免疫プロファイリング解析. 第66回口腔外科学会総会・学術大会 2021.11.12 千葉市

  18. Shimamoto H, Oikawa Y, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Michi Y, Harada H. Analysis of cervical lymph node metastasis at levels IV and V of oral squamous cell carcinoma. 第58回日本癌治療学会学術集会 2021.10.22 横浜市

  19. 釘本 琢磨, 及川 悠, 大迫 利光, 黒嶋 雄志, 平井 秀明, 富岡 寛文, 島本 裕彰, 道 泰之, 原田 浩之. 口腔扁平上皮癌の周術期に血栓症を発症した4例. 日本癌治療学会学術集会抄録集 2021.10.01

  20. 原田 浩之, 及川 悠, 大迫 利光, 釘本 琢磨, 平井 秀明, 富岡 寛文, 島本 裕彰, 道 泰之. 口腔癌に対する治療戦略 口腔癌の新たな治療戦略. 日本癌治療学会学術集会抄録集 2021.10.01

  21. 島本 裕彰, 及川 悠, 大迫 利光, 釘本 琢磨, 黒嶋 雄志, 平井 秀明, 富岡 寛文, 道 泰之, 原田 浩之. 口腔扁平上皮癌レベルIV、V転移症例の検討. 日本癌治療学会学術集会抄録集 2021.10.01

  22. 七宮 蓮, 武井 潤子, 大石 智一, 川田 学, 原田 浩之, 金子 美華, 加藤 幸成. 新規抗EGFRモノクローナル抗体134-mG2aの口腔扁平上皮がん移植片モデルにおける抗腫瘍効果の検討. 日本癌学会総会記事 2021.09.01

  23. 高田嘉宝, 黒嶋雄志, 島本裕彰, 大迫利光, 栢森 高, 池田 通, 原田浩之. 頬リンパ節転移をきたした下顎歯肉扁平上皮癌の一例. 第52回日本口腔外科学会近畿支部学術集会 2021.07.03 WEB開催

  24. Tran Cuong Minh, 黒嶋 雄志, 及川 悠, 道 泰之, 栢森 高, 原田 浩之. 色素性口腔扁平上皮癌の臨床病理学的・免疫組織学的特徴(Clinicopathological and immunohistochemical characteristics of pigmented oral squamous cell carcinoma). 日本口腔科学会雑誌 2021.07.01

  25. Tran MC, Marukawa E, Oshibe N, Uo M, Yoda T, Harada H.. Effects on bone regeneration of different centrifugation conditions and coagulation systems during platelet concentrate and fibrin network formation. 14th Asian Congress on Oral & Maxillofacial Surgery 2021.06.04

  26. Tran Cuong Minh, 黒嶋雄志, 及川 悠, 道 泰之, 栢森 高, 原田浩之. Clinicopathological and immunohistochemical characteristics of pigmented oral squamous cell carcinoma.. 第75回日本口腔科学会学術集会 2021.05.12 豊中市

  27. Yuji Kabasawa, Kanade Ito, Shiori Tokura, Itsuki Takazawa, Ruri Komiya, Hiroyuki Harada, Hitomi Nojima, Masahiko Miura, Ryoichi Yoshimura. Clinical Investigation of Episil Oral Solution for Oral Mucositis during Radiochemical Treatment for Head and Neck Cancer. The 1st Annual Meeting of the International Society of Oral Care 2021.04.18 東京

  28. Kabasawa Yuji, Ito Kanade, Tokura Shiori, Takazawa Itsuki, Kimura Rio, Nakanishi Tohko, Akiyama Kikue, Onuma Yuki, Adachi Toshiko, Komiya Ruri, Harada Hiroyuki, Nojima Hitomi, Miura Masahiko, Yoshimura Ryoichi. 頭頸部がんへの放射線化学療法時に発症する口腔粘膜炎に対して、エピシル口腔用液が及ぼす効果に関するの臨床研究(Clinical Investigation of Episil Oral Solution for Oral Mucositis during Radiochemical Treatment for Head and Neck Cancer). 日本口腔ケア学会雑誌 2021.04.01

  29. 布川 裕規, 坂本 啓, 釘本 琢磨, 道 泰之, 原田 浩之, 山本 正英, 北川 昌伸, 池田 通, 山本 浩平. 硬口蓋に発生したnodular lymphocyte-predominant Hodgkin lymphomaの一例(A case of nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate). 日本病理学会会誌 2021.03.01

  30. Kudo R, Kano Y, Noji R, Yamashita Y, Ishikawa T, Kudo A, Oshima N, Ariizumi Y, Nakagawa T, Mitsumura T, Onishi I, Kimura K, Miya F, Yokobori J, Ohki M, Takamine E, Yoshida M, Tanabe M, Miyake S, Ikeda S. Clinical utility of comprehensive genome profiling using FoundationOne CDx. 第18回日本臨床腫瘍学会学術集会 2021.02.18 WEB開催

  31. Kano Y, Noji R, Yamashita Y, Kudo R, Onishi I, Tanimoto K, Miya F, Nakagawa T, Ishikawa T, Uetake H, Kinugasa Y, Tanabe M, Asakage T, Harada H, Okamoto R, Miyake S, and Ikeda S. Detection of RAS mutation in solid cancers using NGS-based genome profiling tests. 第18回日本臨床腫瘍学会学術集会 2021.02.18 WEB開催

  32. Kano Y, Noji R, Yamashita Y, Kudo R, Tasaki A, Ohno K, Ariizumi Y, Hirai H, Tomioka H, Shimamoto H, Michi Y, Miura M, Yoshimura R, Asakage T, Harada H, Okamoto R, Miyake S, Ikeda S. using NGS-based genome profiling tests. 第18回日本臨床腫瘍学会学術集会 2021.02.18 WEB開催

  33. Sato H, Chen P, Ashida M, Tsutsumi Y, Harada H,Hanawa T. Cytocompatibility of new designed Zr-14Nb-5Ta-1Mo alloy with mouse osteoblastic cells. 第3回日本金属学会 2020.12.12 Web開催

  34. 奥山紘平, 鈴木啓司, 鳴瀬智史, 柳本惣市, 梅田正博, 三浦雅彦, 原田浩之. Potent reduction of cell motility on HNSCC induced by cetuximab demonstrates delayed anti-tumor effect . 第79回日本癌学会学術総会 2020.10.01 広島

  35. 榊谷振太郎, 井上カタジナアンナ, 高橋和樹, 原田浩之, 渡部徹郎. β2-アドレナリン受容体シグナルを標的とした口腔扁平上皮癌の進行の阻害. 第79回日本癌学会学術総会 2020.10.01 広島

  36. 佐山勇輔, 武井潤子, 大石智一、金子美華, 川田 学, 加藤幸成. Antitumor activity against breast cancer using a novel anti-TROP2 monoclonal antibody. 第79回日本癌学会学術総会 2020.10.01 広島

  37. 武井潤子, 金子美華, 大石智一, 佐山勇輔, 川田 学, 原田浩之, 加藤幸成. Development of a monoclonal antibody against human epidermal growth factor receptor 2 (HER2). 第79回日本癌学会学術総会 2020.10.01 広島

  38. 武井 潤子, 金子 美華, 大石 智一, 佐山 勇輔, 川田 学, 原田 浩之, 加藤 幸成. HER2を標的とした抗体医薬開発. 日本癌学会総会記事 2020.10.01

  39. 奥山 紘平, 鈴木 啓司, 鳴瀬 智史, 柳本 惣市, 梅田 正博, 三浦 雅彦, 原田 浩之. セツキシマブによる頭頸部扁平上皮癌細胞の高度の細胞運動能低下は遅発性に抗腫瘍効果をもたらす. 日本癌学会総会記事 2020.10.01

  40. 榊谷 振太郎, 井上 カタジナアンナ, 高橋 和樹, 原田 浩之, 渡部 徹郎. β2-アドレナリン受容体シグナルは口腔扁平上皮癌の進行を阻害する. 日本癌学会総会記事 2020.10.01

  41. 井上 カタジナアンナ, 榊谷 振太郎, 高橋 和樹, 原田 浩之, 渡部 徹郎. 口腔扁平上皮がんに対する新たな治療を目指して. 日本癌学会総会記事 2020.10.01

  42. 加島 義久, 西井 直人, 立浪 秀剛, 永井 重徳, 原田 浩之, 東 みゆき. 境界部に限局したCD8+T細胞と制御性T細胞の浸潤を認める同所性マウス舌扁平上皮癌モデル. 日本癌学会総会記事 2020.10.01

  43. 淺野禎三, 佐山勇輔, 佐野雅人, 武井潤子, 細野秀樹, 金子美華, 加藤幸成. RIEDL tag, a novel peptide tag system is useful for protein purification. 第93回日本生化学会大会 2020.09.16 横浜

  44. 佐野雅人, 淺野禎三, 佐山勇輔, 武井潤子, 細野秀樹, 金子美華, 加藤幸成. DGKzetaに対する新規抗体作製とそのエピトープ解析. 第93回日本生化学会大会 2020.09.16 横浜

  45. Yanagisawa S, Iseki S. Gene expression pattern in osteoblasts derived from craniosynostosis and non-craniosynostosis patients. Gordon Research Conference Craniofacial Morphogenesis and Tissue Regeneration 2020.02.23 Renaissance Tuscany Il Ciocco Lucca (Barga), Italy

  46. Yoshihiro Sasaki, Ryosuke Mizuta, Naoya Kinoshita, Kazunari Akiyoshi . Intracellular delivery of biologics using magnetically-navigated nanocarrier. 第57回日本生物物理学会年会 2019.9.26 2019.09.26 宮崎

  47. Michi Y, Harada H, Hirai H, Mochizuki Y, Kuroshima T, Shimamoto H, Tomioka H. Okuyama K, Kugimoto T, Ohsako T, Kayamori K.. Diffuse larage B-cell lymphoma with initial presentation in the upper and lower jaws. . 7th world congress of the international academy of oral oncology. 2019.9.1 2019.09.01 Rome Italy.

  48. Takeshi KUROSHIMA, Yasuyuki MICHI, Hiroaki SHIMAMOTO, Hirofumi TOMIOKA, Hideaki HIRAI, Takuma KUGIMOTO, Yumi MOCHIZUKI, Kae TANAKA and Hiroyuki HARADA. Contralateral cervical lymph node metastases in tongue squamous cell carcinoma. 7th world congress of the international academy of oral oncology. 2019.9.1 2019.09.01 Rome Italy.

  49. 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 機能的miRNAライブラリースクリーニングによる、BRD4を標的とする新規癌抑制型miRNAの同定(Function-based microRNA library screening identified novel tumor suppressive microRNAs targeting BRD4). 日本癌学会総会記事 2019.09.01

  50. Manila NG, Sakamoto J, Kurabayashi T, Harada H, Tahmasbi-Arashlow M, Nair MK. Odontogenic myxoma: A case report and literature review. 2019 Joint Conference of IADMFR/AAOMR 2019.08.26 Philadelphia, USA

  51. Naoya Kinoshita, Yoshihiro Sasaki, Riku Kawasaki, Eriko Marukawa, Hiroyuki Harada, Kazunari Akiyoshi. Magnetic delivery of transcription factors to stem cells for muscle regeneration. Society For Biomaterials 2019 Annual Meeting and Exposition 2019.4.3-6 2019.04.03 Seattle

  52. 石田 尚子, 栢森 高, 坂本 啓, 行森 茜, 釘本 琢磨, 原田 浩之, 池田 通. 粘表皮癌におけるFUCA1の発現と病理組織診断への応用(The expression of FUCA1 in mucoepidermoide carcinoma and application to histopathological diagnosis). 日本病理学会会誌 2019.04.01

  53. Yuki Takagawa, Yasuyuki Gen, Tomoki Muramatsu, Hiroyuki Harada, Johji Inazawa. Exploring novel tumor suppressive microRNAs in OSCC. ISPCM ANNUAL MEETING 2019 2019.3.12 2019.03.12 Seoul Dongdaemun, Korea

  54. Naoya Kinoshita, Yoshihiro Sasaki, Riku Kawasaki, Eriko Marukawa, Hiroyuki Harada, Kazunari Akiyoshi. Magnetic nanogel delivery of transcription factor to adipose-derived stem cell for muscle tissue regeneration. Kyoto Winter School 2019 "Quantifying Dynamics of Life" 2019.3.11-20 2019.03.11

  55. Kaifeng LUO, Yutaka MARUOKA, Rie KINOSHITA, Teru OKITSU, Libo WU, Nobuyuki TAKAMA, Beomjoon KIM. Modeling of stomatitis in rats and novel treatment using microneedles-based patch. IEEE CPMT Symposium Japan 2018 (ICSJ 2018) 2018.11.19 京都

  56. Hideaki HIRAI, Hirofumi TOMIOKA, Yumi MOCHIZUKI, Takeshi KUROSHIMA, Fumihiko TSUSHIMA, Hiroaki SHIMAMOTO, Hiroyuki HARADA. Clinical Course of Oral Squamous Cell Carcinoma in Patients on Immunosuppressant and Glucocorticoid Therapy. 13th Asian Congress on oral and maxillofacial surgery 2018.11.08 台北

  57. Takeshi KUROSHIMA, Hiroaki SHIMAMOTO, Hirofumi TOMIOKA, Hideaki HIRAI, Yumi Mochizuki, Kae TANAKA and Hiroyuki HARADA. Clinicopathological analysis for N0 tongue squamous cell carcinoma with occult cervical lymph node metastasis. 13th Asian Congress on oral and maxillofacial surgery 2018.11.08 台北

  58. Mari SHIBATA, Yasuyuki MICHI, Hiroyuki HARADA, Tetsuya YODA. Clinical histopathological study on tongue cancer accompanying revisions of the 8th edition of the AJCC/ UICC staging manuals. 13th Asian Congress on oral and maxillofacial surgery 2018.11.08 台北

  59. Eriko MARUKAWA, Narumi OSHIBE, Hiroyuki HARADA, Yoshihiro SASAKI, Kazunari AKIYOSHI. Osteoinduction Using β-TCP and Nanogel-Crosslinking Hydrogel as a Novel Scaffold for BMP-2.. The 12th International BMP Conference 2018.10.24 東京

  60. Hiroaki SHIMAMOTO, Shuhei FUKUDA, Yu OIKAWA, Toshimitsu OSAKO, Takuma KUGIMOTO,Takeshi KUROSHIMA, Hideaki HIRAI, Yumi MOCHIZUKI, Kae TANAKA, Hirofumi TOMIOKA, Hiroyuki HARADA. Clinical analysis of lymph node metastasis of patients with cN0 oral squamous cell carcinoma. 第56回日本癌治療学会 2018.10.18 横浜

  61. 島本 裕彰, 福田 修平, 及川 悠, 大迫 利光, 釘本 琢磨, 黒嶋 雄志, 平井 秀明, 望月 裕美, 田中 香衣, 富岡 寛文, 原田 浩之. 口腔扁平上皮癌cN0症例の頸部転移についての検討. 日本癌治療学会学術集会抄録集 2018.10.01

  62. Yuki TAKAGAWA, Yasuyuki GEN, Tomoki MURAMATSU, Hiroyuki HARADA, Johji INAZAWA. Exploring novel tumor suppressive microRNAs in OSCC. 第77回日本癌学会学術総会 2018.09.27 大阪

  63. Shunsuke ITAI, Tomokazu OHISHI, Mika K. KANEKO, Shinji YAMADA, Shinji ABE, Yasuhiko NISHIOKA, Hiroyuki HARADA, Yukinari KATO. Antitumor activity by ADCC against oral squamous cell carcinomas by anti-podocalyxin antibody. 第77回日本癌学会学術総会 2018.09.27 大阪

  64. Shimada Y, Kawasaki Y, Hagiwara S, Nakamura F, Maruoka Y. Importance of eliminating potential dental focal infection before hematopoietic stem cell transplantation: A retrospective cohort study in Japan. The 14th Biennial Congress of the European Association of Oral Medicine (EAOM) in conjunction with the World Workshop Ⅶ on Oral Medicine 2018.09.27 Gothenburg(Sweden)

  65. Namiaki TAKAHARA, Atsushi KIMURA, Yusuke HIGUCHI, Yuji KABASAWA, Tetsuya YODA, Hiroyuki HARADA. Evaluation Of Postoperative Mandibular Stability After Bimaxillary Surgery For Mandibular Setback And The Clockwise Rotation Of The Proximal Segment. 24th Congress of the European Association for Cranio Maxillo Facial Surgery 2018.09.18 Munich(Germany)

  66. 板井 俊介, 大石 智一, 金子 美華, 山田 慎二, 阿部 真治, 西岡 安彦, 川田 学, 原田 浩之, 加藤 幸成. 口腔扁平上皮癌における抗ポドカリキシン抗体のADCCによる抗腫瘍効果(Antitumor activity by ADCC against oral squamous cell carcinomas by anti-podocalyxin antibody). 日本癌学会総会記事 2018.09.01

  67. 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 口腔扁平上皮癌における新規のがん抑制型マイクロRNAの探索(Exploring novel tumor suppressive microRNAs in OSCC). 日本癌学会総会記事 2018.09.01

  68. Kaifeng LUO, Yutaka MARUOKA, Rie KINOSHITA, Teru OKITSU, Libo WU, Nobuyuki TAKAMA, Beomjoon KIM. Study on the use of dissolvable microneedles in the treatment of stomatitis. The International Symposium on Precision Engineering and Sustainable Manufacturing (PRESM 2018) 2018.07.03 札幌

  69. Naoto NISHII, Hidetake TACHINAMI, Yuta KONDO, Yulong XIA, Yoshihisa KASHIMA, Tatsukuni OHNO, Shigenori NAGAI, Lixin LI, Walter LAU, Hiroyuki HARADA and Miyuki AZUMA. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. 15th International symposium on dendritic cells 2018.06.09 Aachen (Germany)

  70. Shunsuke ITAI, Mika K. KANEKO, Shinji YAMADA, Yukinari KATO. A core fucose-deficient anti-podocalyxin antibody exhibits anti-tumor activity via augmented antibody-dependent cellular cytotoxicity in oral squamous cell carcinoma. America association for cancer research(2018) 2018.04.18 Chicago(USA)

  71. Yukinobu TAKAHASHI, Eriko MARUKAWA, Hiroyuki HARADA. The use of a new porous hydroxyapatite-collagen composite in a ridge preservation. 2018 AO Annual Meeting 2018.02.28 Los Angeles(USA)

  72. Nishii Naoto, Tachinami Hidetake, Yoshihisa Kashima, Kondo Yuta, Harada Hiroyuki, Azuma Miyuki. 癌免疫療法併用 免疫チェックポイント阻害薬を超えて PD-1チェックポイント阻害抵抗性および制御性T細胞優位のマウス腫瘍モデルにおける低用量TLR7作動薬の全身投与は抗腫瘍応答を増大させる(Combination cancer immunothrapy: beyond immune checkpoint inhibitors Systemic administration of low dose TLR7 agonist augments antitumor responses in the PD-1 checkpoint blockade-resistant and regulatory T cell-dominant murine tumor models). 日本免疫学会総会・学術集会記録 2017.12.01

  73. Shimada Y, Kawasaki Y, Ide K, Sato I, Hagiwara S, Yamada H, Maruoka Y. Differential diagnosis of fever in patients with hematologic malignancy receiving chemotherapy: A retrospective cohort study in Japan. 99th the American Association of Oral and Maxillofacial Surgeons(AAOMS) Annual Meeting Oct 9-14th 2017 2017.10.09 San Francisco

  74. 板井 俊介, 山田 慎二, 金子 美華, 張 耀文, 国田 朱子, 深山 正久, 原田 浩之, 加藤 幸成. 口腔がんに対する免疫染色に有用な抗ポドカリキシン抗体PcMab-47の樹立. 日本癌学会総会記事 2017.09.01

  75. 高原 楠旻, 中川 聡, 角倉 可奈子, 坂本 一郎, 原田 浩之. 顎関節痛とMRI所見の関連について(Association of TMJ pain according to magnetic resonance imaging findings in TMD patients). 日本顎関節学会雑誌 2017.07.01

  76. Uo M, Wada T, Komiya R, Harada H, Sakamoto K, Ikeda T, Yamaguchi A. Trace metallic element accumulation in the sequestrum of medication-related osteonecrosis of the jaw (MRONJ). 14th International Symposium on Applied Bioinorganic hemistry – ISABC14 June 7-10th 2017 2017.06.07 Toulouse, France

  77. Miyazaki H,Wada Y,Tanaka K,Harada H,Asamura S. Treatment strategies for oral vascular anomalies: Approaches to massive lesions using intralesional laser photocoagulation. European Congress of Laser Dentistry, March 30-April 1 2017. 2017.03.30 Plovdiv

  78. Shimada Y,Nakagawa Y,Ide K,Sato I,Hagiwara S,Yamada H,Kawasaki Y,Maruoka Y . Oral adverse event and the risk factor in patients with hematologic malignancy receiving chemotherapy: A retrospective cohort study in Japan. The 98th Annual Meeting of American Association of Oral and Maxillofacial Surgeons (AAOMS) Sep 18-23, 2016. 2016.09 Las Vegas

  79. Miyazaki H,Romeo U,Wada Y,Kato J,Tanaka K,Alessandro DV, Maruoka Y, Watanabe H,Harada H,Asamura S. Treatment strategies for large oral vascular anomalies using intralesional laser photocoagulation. The 15th Congress of the World Federation for Laser Dentistry, July 17-19 2016. 2016.07.17 Aichi

  80. Hidetaka Miyazaki,Umberto Romeo,Yoshitaka Wada,Junji Kato,Kae Tanaka,Alessandro Del Vecchio,Yutaka Maruoka,Hisashi Watanabe,Hiroyuki Harada,Shinichi Asamura. Treatment strategies for large oral vascular anomalies using intralesional laser photocoagulation. The 15th Congress of the World Federation for Laser Dentistry (WFLD) Jul 17-19 2016 2016.07 Nagoya

  81. Takahara N, Kabasawa Y, Tetsumura A, Kurabayashi T, Harada H. Dynamic MR imaging of the temporomandibular joint: a preliminary study. Advanced Digital Technology (ADT) North America & Japan Regional Leadership Groups Conference,June 16-20 2016. 2016.06.16 San Diego

  82. Kabasawa Y, Tsuchida Y, Takahara N, Kamijo S, Suzuki T. :Accuracy of a 3D Model for Surgical Support in Orthognathic Surgery- Efficacy of Data Synthesis with Computed Tomography and Dental Model Scan-. Advanced Digital Technology (ADT) North America & Japan Regional Leadership Groups Conference, June 16-20 2016. 2016.06.16 San Diego

  83. Nishii N, Kondo Y, Li L, Lau W, Hi, Harada H, Azuma M. Combined treatment with PD-L1 blockade and a TLR7/8 agonist dramatically enhances antitumor immunity. AACR2016 2016.04.16 New Orleans, LA, USA Ernest N. Morial Convention Center

  84. Morita K, Naruto T, Tanimoto K, Yasukawa C, Oikawa Y, Masuda K, Imoto I, Inazawa J, Omura K, Harada H. Simultaneous detection of both single nucleotide variations and copy number alterations by next-generation sequencing in gorlin syndrome. The 13th International Congress of Human Genetics, April 3-7 2016 2016.04.03 Kyoto

  85. Marukawa E, Harada H, Sasaki Y, Akiyoshi K. Osteoinduction using β-TCP with Nanogel-crosslinking hydrogel as Nobel scafford for BMP-2. Academy of Osseointegration's 31st Annual Meeting, February 17-20 2016. 2016.02.17 San Diego

  86. Marukawa E, Stricker A, Fleiner J, Flugge TV, Harada H, Schmelzeisen R, Nelson K. The difference in bone resorption between mandibular ramus bone block graft and bone splitting for alveolar ridge augmentation. Academy of Osseointegration's 31st Annual Meeting, February 17-20 2016. 2016.02.17 San Diego

  87. Takada J, Ogawa T, Sato C, Uezono M, Morita M, Moriyama K. A case of Holoprosencephaly with unilateral cleft lip and palate treated with maxillary distraction osteogenesis in adolescence. The 8th International Orthodontic Congress 2015.09.28 London, UK

  88. Morita K, Oikawa Y, Kayamori K, Sakamoto K, Ishikawa S, Inazawa J, Harada H. Targeted resequencing of cancer-related genes in oral cancer. The 34th Sapporo International Cancer Symposium 2015.06.26 Sapporo, Japan

  89. Morita K. Distraction osteogenesis for patients with cleft lip and palate at Tokyo Medical and Dental University. The 56th Congress of the Korean Association of Oral and Maxillofacial Surgeons. Symposium II: DO & Deformity 2015.04.24 Goyang, Korea

  90. Harada H. Prediction of cervical lymph node and distant metastasis in oral carcinoma. TMU-TMDU Joint Symposium 2015 2015.03.14 Tokyo, Japan

  91. Haraguchi M, Yamashiro M, Sumita YI, Mizutani M, Michi Y, Tachikawa N, Kasugai S, Harada H, Harada K, Taniguchi H. Impact factors for chewing function in maxillectomy patients. 38th annual conference of the European prosthodontic association and 21st scientific congress of the Turkish prosthodontic and implantology association 2014.09.26 Istanbul, Turkey

▼display all

Awards & Honors 【 display / non-display

  • 14th Asian Congress on Oral & Maxillofacial Surgery (ACOMS) Oral Paper Competition runner up,Asian Congress on Oral & Maxillofacial Surgery (ACOMS),2021.06

  • Young Scientists Award,Cancer Science,2019.09